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Since the 1960s, cannabis has gained enormous popularity. Nowadays, cannabis is the most 
widely used drug worldwide. It has been estimated that 78 million people (aged 15 – 64) have 
used cannabis at least once in European countries (European Monitoring Centre for Drugs and 
Drug Addiction (EMCDDA), 2011). Also, an estimated 23 million have used cannabis in the 
last year, which represents 6,7 % of all 15 – 64 year olds  (EMCDDA, 2011). Cannabis use 
has become especially prevalent among 15-24 year olds. In 1990, it was estimated that about 
5 % had used cannabis in the past year. This number has increased rapidly; based on the 2011 
survey reports, about 12.1 % of 15-24 year olds have used it in the past year and 6.6 % in the 
past month (EMCDDA, 2011). Research in countries outside Europe, including the US, New 
Zealand and Canada, has shown a high prevalence among young adults as well (EMCDDA, 
2011). Interestingly, despite the fact that the Netherlands is the only country where possession 
of up to five grams of cannabis is not legally prosecuted, prevalence rates of cannabis use are 
higher in other countries. For example in 2009, annual prevalence within the adult population 
(aged 15-64 years) was far higher in the US (11%) and Australia / New Zealand (15 %) than 
in the Netherlands (7%) (EMCDDA, 2011; UNODC, 2012).  
Along with increasing prevalence rates, the level of delta-9-tetra-hydrocannabinol (Δ9-THC) 
has increased over the past years, in particular in Dutch weed (EMCDDA 2011; Pijlman et al., 
2005). THC is the primary (psycho-)active ingredient of cannabis, and it has been argued that 
higher levels of THC may yield stronger effects. THC concentrations in imported marijuana 
remained stable (Pijlman et al., 2005). In 2004, Dutch marijuana contained on average 20 % 
THC levels, whereas THC levels in imported marijuana was around 7 %. In 2008, THC levels 
in European marijuana ranged between 3 – 16 %, again with especially high levels in Dutch 
marijuana (EMCDDA, 2011). These higher levels of THC concentrations, in combination 
with an increase in prevalence rates, may contribute to cannabis abuse and dependency 
problems (Cooper & Haney, 2009). 
Whereas this is still subject to further investigations, indications for associations with (mental) 
health problems are strong enough to validate further research into (risk) factors associated 
with (the initiation of) cannabis use. It is important to study such possible (risk) factors of 
cannabis use as early in life as possible, as it has been shown that early initiation of cannabis 
use is associated with an increased risk of escalation to heavier cannabis use, and to the use of 
other illicit drugs (Coffey et al., 2000; Lynskey et al., 2002; Lynskey et al., 2006). Early onset 




experiencing any adverse health effects that cannabis use may have in later adult life (e.g. 
Moore et al., 2007; Patton et al., 2002). According to Hawkins, Catalano & Miller’s (1992) 
and Petraitis, Flay & Miller’s (1995) risk factor taxonomy, risk factors for the initiation of 
cannabis use or extent of cannabis use can be summarized into four categories: (1) Socio-
environmental variables (e.g. male gender, low SES, unemployment, financial situation); (2) 
substance-related variables (e.g. easy availability of drugs, drug-using peers, positive attitude 
towards drugs, prior history of tobacco, alcohol, or other illicit drug use); (3) intrapersonal 
variables (e.g. mental health problems) and (4) interpersonal variables (e.g. family 
functioning, relationship with mother, not having been brought up by both parents) (Von 
Sydow et al., 2002). The focus of the present thesis is on intrapersonal variables, including 
vulnerability for psychosis and internalizing and externalizing behaviour problems, which 
may be correlates of cannabis use. In addition to factors that have been more or less 
established as intrapersonal risk factors, there will be an emphasis on social functioning (more 
specifically, lack of social skills) as a risk factor for cannabis use, its initiation and its 
frequency. Although social functioning in general may also be considered an interpersonal 
risk (or protective) factor, specific social skills appear to classify more readily as intrapersonal 
risk (or protective factors). Lastly, we will focus on (specific) cognitive weaknesses in 
cannabis users, which may also classify as intrapersonal risk factors. 
 
Cannabis Use and Mental Health  
Research reveals that regular cannabis use is strongly correlated with use of alcohol, smoking, 
and use of other (illicit) drugs (Fergusson, Boden & Horwood, 2006, Fergusson et al., 2002a; 
Lynskey et al., 2003), and is related to delinquency, unemployment, risky sexual behaviour, 
affiliation with delinquent peers, school dropout and reduced educational achievement 
(Fergusson & Horwood, 1997; Fergusson et al., 2002b; Lynskey & Hall, 2000). Also, 
cannabis use, in particular regular use, has been associated with a wide range of mental health 
problems, including psychotic disorders (Arseneault et al., 2002; van Gastel et al., 2012; 
Malone et al., 2010; Moore et al., 2007; van Os et al., 2002), externalizing problems 
(aggressive and delinquent behaviour) (Monshouwer et al., 2006), depression (Degenhardt et 
al., 2001; Degenhardt et al., 2003; Patton et al., 2002) and anxiety (Hayatbakhsh et al., 2007; 
Patton et al., 2002; van Laar et al., 2007).  
Associations between cannabis use and different mental health problems, including 




examined further. One important issue to investigate is the temporal order of the associations. 
Different hypotheses have been put forward to try to explain these associations, including the 
damage hypothesis, the self-medication hypothesis, the vulnerability hypothesis and the 
shared causes hypothesis. According to the 'damage hypothesis', the association between 
cannabis and mental health problems reflects cause and effect associations in which the use of 
cannabis leads to the development of various mental health problems (Brook, Cohen & 
Brook, 1998; Kandel, Yamaguchi & Chen, 1992).  For example, Moore et al. (2007) 
concluded that cannabis use increases the risk of psychosis by 14 %. Alternatively, the 'self-
medication hypothesis' proposes that cannabis use might be the result rather than the cause of 
mental health problems, as adolescents with mental health problems tend to resort to drug use 
to ‘sooth painful feelings’ rather than  to seek pleasure (Khantzian , 1985). Previous evidence 
for the self-medication hypothesis stems mostly from clinical observations of patients 
suffering from psychiatric disorders (e.g. Klein et al., 1994; Warner et al., 1994). However, 
empirical studies and clinical observations have not consistently provided evidence for either 
the damage- or the self-medication hypothesis. Following the lack of consistency in results 
supporting these hypotheses, it has been suggested that cause and effect might be moderated 
by particular forms of vulnerability (the 'vulnerability hypothesis'), i.e. the linkage between 
cannabis use and mental health problems might be particularly evident in individuals who are 
- due to their biological, personal or familial make-up - sensitive to the damaging effects of 
cannabis or more likely to use drugs for their soothing effects (Caspi et al., 2005; Henquet et 
al., 2005; Miller et al., 2001; Verdoux et al., 2003). It should be noted that it is not entirely 
clear which biological, personal or familial factors might constitute particular risk enhancers 
for mental health problems when present together with cannabis use. A further issue is finding 
the best possible measures through which such moderating risk factors express themselves. 
For example, Caspi and colleagues (2005) showed that carriers of the catechol-O-
methyltransferase (COMT) valine158 allele were most likely to exhibit psychotic symptoms if 
they used cannabis. Functional polymorphisms of other genes as well as several 
environmental factors (e.g. stress) have also been shown to moderate the effects of cannabis 
considering the development of different forms of psychopathology (Henquet et al., 2008). 
Even though a number of these interactions were replicated (Gill et al., 2010; Rijsdijk et al., 
2011), the amount of variance in mental health problems explained by single gene 
polymorphisms or environmental factors remains limited. Thus, it may be preferable to study 
intermediate cognitive phenotypes, which have generally been associated with multiple gene 




the vulnerability hypothesis may have many different faces and should be investigated more 
thoroughly. Moreover, it is related-, but not entirely similar to the so-called 'shared causes 
hypothesis'. This last type of hypothesis implies that the linkage between cannabis use and 
mental health problems is largely non-causal and may be the result of several factors 
associated with the use of cannabis and mental health problems (simultaneously), such as 
disadvantaged backgrounds (including low SES; low maternal education; growing up in a 
single parent family; poorer parental attachment) and difficult childhood circumstances 
(including family dysfunction, crime, depression, anxiety, suicidal behaviours, exposure to the 
use of (illicit) substances) (Fergusson & Horwood, 1997; Fergusson, Horwood & Swain-
Cambell, 2002a). Thus, this hypothesis states that the higher rate of mental health problems 
found among cannabis users arises because cannabis use is more common in individuals 
exposed to other possible causes of mental health problems. As with the vulnerability 
hypothesis, there are many different (other) factors that might play a role in the development 
of mental health problems. The main difference between the two types of hypotheses is that 
the vulnerability hypotheses state that co-occurring cannabis use and other risk factors 
constitute supra-additive effects on mental health, whereas the shared-causes hypotheses 
particularly involve mediating effects of other risk factors on cannabis-mental health 
associations.     
 
Although many studies have focused on cannabis use and mental health outcomes, including 
psychosis and both internalizing and externalizing behaviour problems, little is known about 
this relationship during (early) adolescence. This seems crucial, since adolescence is a life 
phase characterized by significant biological changes and consecutive maturation processes, 
especially neurologically, which might increase vulnerability to enduring effects of external 
influences like such as exposure to cannabis (Bossong & Nieding., 2010; Schneider, 2008). 
The first aim of this dissertation is to determine the temporal order of cannabis use and mental 
health problems, including vulnerability for psychosis, internalizing and externalizing 
problems, thereby testing the damage hypothesis, the self-medication hypothesis and the 
shared-causes hypothesis.  
 
Cannabis use and Social Functioning  
Associations between social functioning and cannabis use have not yet been extensively 




in this age range generally use cannabis in social contexts (e.g. at parties, dancing clubs or on 
the street). Indeed, some of the most frequently reported reasons for using cannabis by young 
adults are of a social nature, i.e. ”to bond with friends” or to “hang out” (Lee et al., 2007). 
Another reason for engaging in cannabis use is conformity, in other words, “under peer 
pressure” or “because friends do it” (Simons et al., 1998). Taken together, cannabis can be 
seen as a social drug, and many of the reported motives for engaging in cannabis use are 
socially-driven.  
There has been relatively little research focusing on possible prospective associations between 
social parameters and cannabis use during adolescence. Cross-sectional studies have shown 
that adolescents who experiment with cannabis show lower levels of social self-control and 
higher levels of negative self-esteem compared to non-users (Sussman et al., 2003; Veselska 
et al., 2009). Such results appear to indicate relatively poor social adjustment among cannabis 
users. Also, although being under the influence of cannabis has been associated with increases 
in the extent of social interactive behaviour, the quality of such behaviour (e.g. of verbal 
exchanges during these social interactions) has been shown to be relatively low (Foltin et al., 
1987, 1988). Other studies, however, showed that cannabis users displayed higher levels of 
social competence (e.g. assertive behaviour) compared to non-users, without apparent 
differences in the quality of such behaviour (e.g. Shedler & Block, 1990; Veselska et al., 
2009). Such results lead to the hypothesis that socially competent adolescents may find 
themselves in social contexts more often, where the probability of exposure to cannabis is 
higher. Other studies have found similar results, namely that those who experiment with 
cannabis during adolescence are socially better adjusted and have better social skills than both 
abstainers and heavy users (Engels & Ter Bogt; 2001; Shedler & Block, 1990). Pokhrel et al. 
(2007) investigated the prospective relationship between cannabis use and social self-control. 
Lack of social self-control refers to one’s tendency to ‘act without thinking’ (Tarter, 1988), 
especially in a social context. Results showed a reciprocal relationship between social self-
control and cannabis use. Lack of social self-control increased cannabis use, which in turn 
decreased social self-control.   
Studies describing social functioning in cannabis users have predominantly focused on 
psychopathology and associated negative effects on social behaviour. Indeed, psychosis, 
internalizing- and externalizing behavioural problems, which are obviously characterized by 
social dysfunction, have been associated with cannabis use (Moore et al., 2007; Degenhardt et 
al., 2003; Fergusson et al., 2002a). However, cannabis is used very frequently and by many 




psychopathology. These individuals could, however, still experience social problems with 
potential impact upon everyday life. To our knowledge, there are no studies focusing 
specifically on social skills as predictors of cannabis use.  
Therefore, another aim of the present thesis is to study cannabis use and its relation to social 
parameters. More specifically, the focus will be on (lack of) different social skills 
(cooperation, assertion and self-control) as possible risk factors of cannabis initiation and 
frequency of cannabis use (chapter 4).  
 
The above research questions on mental health (Chapter 2 and 3), social functioning (Chapter 
4) and cannabis use will be studied using data from a large prospective cohort study called 
TRAILS (Tracking Adolescents’ Individual Lives Survey), which follows Dutch adolescents 
biennially, starting at the age of 10-12 years at the first assessment (chapter 2-3-4). Due to a 
lack of available data on specific possible moderating factors such as particular gene 
polymorphisms and their associated cognitive profiles, (variants of) the vulnerability 
hypothesis were not tested in this sample. In chapter 5 and 6 of this thesis moderating effects 
of cognitive abilities on cannabis use predicting psychological problems are tested in a 
different sample, consisting mainly of undergraduate students. The TRAILS-sample was used 
for a related research question featuring in this thesis, i.e. whether social functioning predicts 
(different aspects of) cannabis use. Social functioning could be regarded as another 
intermediate phenotype in associations between cannabis use and mental health, and might 
therefore also moderate such associations. It may be argued, however, that social functioning 
is not a very unitary concept, i.e. it contains many subcomponents and different 
operationalizations as well as its own broad set of determining factors. Thus, if an interaction 
between cannabis use and social functioning in the prediction of psychological problems 
would be observed, this would not yet provide very detailed information on (constellations of) 
risk factors for poor mental health. Moreover, social functioning has, perhaps unfortunately, 
not yet been extensively studied in relation to cannabis use. 
 
Cannabis use and Cognitive Functioning  
Another important factor to study in relation to cannabis use is cognitive functioning, which 
may be related to both initiation and continuation of drug use, as well as transition to more 
serious use of cannabis or other drugs. It has proven to be difficult to pinpoint specific 




reason is that cognitive weaknesses generally do not appear to be specific to cannabis use: 
similar weaknesses can be found among users of other substances. A second reason lies in 
methodological issues, i.e. the means of assessment of certain cognitive constructs, the 
definition of those constructs, and differing sample characteristics.  
Cognitive impairments that have been associated with cannabis use involve executive 
function (EF), implicit cognition, episodic memory, and emotional processing (Pope et al., 
2001; Solowij, 1998; Solowij et al., 2002; Stacy and Wiers, 2010; Verdejo-Garcia, Lawrence 
& Clark, 2008). Except perhaps episodic memory, these are all broadly defined constructs. 
Core EF-abilities include inhibitory control and working memory, which are multi-faceted 
concepts themselves (cf. Christ et al., 2010; D’Esposito et al., 1999; Nigg, 2000). Core 
aspects of emotional processing include social perception (e.g. emotion recognition), Theory 
of Mind (i.e. the ability to “mentalize"), empathy, and reward/punishment sensitivity 
(Adolphs, 2002; Beer et al., 2004; Dodge and Rabiner, 2004; Ochsner, 2008; Pettit and Mize, 
2007). Studies investigating cognitive correlates of cannabis use have often employed task 
paradigms addressing combinations of different (social-) cognitive skills. Examples include 
decision-making and implicit cognition tasks, which require working memory, and cognitive 
and motivational inhibitory control (Busemeyer and Stout, 2002; Stacy and Wiers, 2010; 
Whitlow et al., 2004).  
In this thesis, the focus will be on more specific cognitive constructs that may underlie or 
follow cannabis use, i.e. motivational versus cognitive inhibitory control (chapter 5) and 
social perception (chapter 6). Contrasting cognitive and motivational inhibitory control is 
based on the taxonomy of executive function proposed by Zelazo and Müller (2002). Zelazo 
and Müller (2002) distinguish executive functions along “hot” and “cool” dimensions. Hot EF 
involves affect and motivation, either inherent in the task or the context in which a task has to 
be performed, while cool EF does not involve such components or contexts and is more 
related to basic abilities. This taxonomy has been supported by neuroanatomical and 
developmental studies (Kerr & Zelazo, 2004; Prencipe et al., 2011; Zelazo & Müller, 2002)   
Results of several (recent) studies suggest that cognitive deficits in cannabis users 
(particularly in “non-addicted” users) may only become apparent when a task involves an 
affective/motivational component or has to be performed in a context containing such 
elements. In order to test this hypothesis, contrasting performance on tasks with and without 
such components is required.  
The choice to investigate social perception is based on recent research findings (Platt et al., 




following cannabis use) ((Yucel et al., 2008), thereby taking into account the evidence for 
amygdale-involvement in social perception (Adolphs, 2002; Ochsner, 2008), and the central 
role of social perception in affective/motivational information processing. Another very 
important argument to investigate social perception is that this aspect of cognition (similar to 
other aspects of cognition associated with affect and motivation) has repeatedly been 
associated with the types of psychological problems that have also been associated with 
cannabis use, including (subclinical) levels of psychosis/schizophrenia, and internalizing and 
externalizing behaviour problems (Demenescu et al., 2010; Germine and Hooker, 2011; Kiehl 
et al., 2000; Kohler et al., 2010; Marsh and Blair, 2008; Nigg et al., 1998; Raaijmakers et al., 
2008; Riggs et al., 2006; Rössler et al., 2011). As for the study of cognitive versus 
motivational inhibitory control, a contrast will be introduced in order to allow more specific 
statements on the cognitive profile of cannabis users. This contrast is provided as one of the 
tasks that will be used involves actual emotion recognition whereas the other task does not. 
Moreover, the two tasks that are used differ in the amount of working memory capacity that 
has to be allocated to achieve optimal performance. Again similar to the cognitive versus 
motivational inhibition study, interrelations between possible cognitive impairments and 
psychological problems will be investigated, incorporating both mediating and moderating 
effects.  
 
For investigation of the above research questions on cognition and cannabis use (Chapter 5 
and 6), we did not make use of the TRAILS-sample. A disadvantage of this is that the self-
medication and damage-hypotheses could not be investigated, as for samples that were used 
here (see Samples and Methods-sections below) no longitudinal data were available. We did 
however add to the existing literature on cannabis and cognition by adding associations with 
behaviour in daily life and psychological problems. Moreover, we tested the vulnerability 
hypothesis by examining whether cannabis users with relatively poor cognitive skills 





Research questions  
The first aim of this dissertation is to determine the temporal order of cannabis use and mental 
health problems during (early) adolescence. Secondly, we will focus on social parameters in 
association with cannabis use. The third aim of this thesis is to investigate cognitive correlates 
of cannabis use, thereby specifically investigating their roles in cannabis-behaviour 
associations.   
 
The main research questions of this thesis are:  
1. Is there a relationship between cannabis use and both internalizing and externalizing 
behaviour problems in early adolescence? And if so, what is the temporal order of 
these relationships? 
2. Is there a relationship between cannabis use and vulnerability for psychosis, as 
measured by social problems, thought problems and attentional problems, in 
adolescence? And if so, what is the temporal order of this relationship?  
3. Are the social skills cooperation, assertiveness and self-control precursors of cannabis 
use during early adolescence? Specifically, are these social skills precursors of (early) 
cannabis initiation and the frequency of use?  
4. Do cannabis users experience problems with motivational inhibitory control, cognitive 
inhibitory control or both? Also, do cannabis users experience problems in 
behavioural impulsivity, and is this related to motivational and/or cognitive inhibitory 
control?  
5. Do cannabis users experience problems with respect to social perception? Also, are 









Samples en Methods 
For the present thesis, three different samples were used. The first 3 research questions 
concerning mental health and social functioning were studied in a population-based sample, 
the cognitive processes (research questions #4 and #5) were studied in two samples of 
(mostly) undergraduate students. Details of the datasets are provided below.  
 
1. TRAILS Sample 
The study described in this thesis was embedded in the Tracking Adolescents’ Individual 
Lives Survey (TRAILS) (de Winter et al., 2005; Huisman et al., 2008). TRAILS is a large 
prospective cohort study of Dutch adolescents initially aged 10-12 years, who are measured 
biennially at least until they are 24 years old. The key objective of TRAILS is to chart and 
explain the development of mental health from preadolescence into adulthood, both at the 
level of psychopathology and the levels of underlying vulnerability and environmental risk. 
For the present thesis, data from the first (2001-2002), second (2003-2004), third (2005-2007) 
and fourth (2008-2010) assessment waves were used. The TRAILS target sample involved 
young adolescents living in five municipalities in the North of the Netherlands, including both 
urban and rural areas.  
Sample selection involved two steps. First, the municipalities selected were requested to give 
names and addresses of all inhabitants born between 10-01-1989 and 09-30-1990 (first two 
municipalities) or 10-01-1990 and 09-30-1991 (last three municipalities), yielding 3483 
names. Simultaneously, primary schools (including schools for special education) within 
these municipalities were approached with the request to participate in TRAILS; i.e., pass on 
students’ lists, provide information about the children’s behaviour and performance at school, 
and allow class administration of questionnaires and individual testing (neurocognitive, 
intelligence, and physical) at school. School participation was a prerequisite for eligible 
children, before parents were approached by the TRAILS staff, with the exception of children 
already attending secondary schools (< 1%), who were contacted without involving their 
schools. Of the 135 primary schools within the municipalities, 122 (90.4% of the schools 
accommodating 90.3% of the children) agreed to participate in the study.   
If schools agreed to participate, parents (or guardians) received two brochures, one for 
themselves and one for their children, with information about the study; and a TRAILS staff 
member visited the school to inform eligible children about the study. Approximately one 




information, answer questions, and ask whether they and their son or daughter were willing to 
participate in the study. Respondents with an unlisted telephone number were requested by 
mail to pass on their number. If they reacted neither to that letter, nor to a reminder letter sent 
a few weeks later, staff members paid personal visits to their house. Parents who refused to 
participate were asked for permission to call back in about two months to minimize the 
number of refusals due to temporary reasons. If parents agreed to participate, an interview 
was scheduled, during which they were requested to sign an informed consent form. Children 
were excluded from the study if they were incapable to participate due to mental retardation 
or a serious physical illness or handicap; or if no Dutch-speaking parent or parent surrogate 
was available, and if it was not feasible to administer part of the measurements in the parent’s 
language.  
Of all children approached for enrollment in the study (i.e., selected by the municipalities and 
attending a school that was willing to participate, N =  3145), 6.7% were excluded because 
incapability or language problems. Of the remaining 2935 children, 76.0% (N = 2230, mean 
age = 11.09, SD = 0.55, 50.8% girls) were enrolled in the study (i.e., both child and parent 
agreed to participate). Responders and non-responders did not differ with respect to gender, 
parental education, proportion of single-parent families, teacher-rated problem behaviour, or 
school absence; but children in the non-response group needed additional help for learning 
difficulties more frequently. At T2, 96.4% of these participants (N=2149) were re-assessed, 
mean age 13.56 years; SD 0.53; 51.0% girls. T3 was completed with 81.4 % of the original 
number of participants (N=1816), mean age 16.27 years old; SD 0.73 and 52.3% girls. During 
T3, 42 subjects were unable to participate in the study, due to mental/physical health 
problems, death, emigration, detention or by being untraceable. With these subjects left out, 
response rate increases to 83.0%. T4 was completed with 84.3% of the original sample (total 
n = 1881, mean age 19.1 (SD 0.60), 52.3% girls) (Nederhof et al., 2012). 
The number of individuals that were included in the analyses differs for the separate chapters 
of this thesis (specifically chapter 2-3-4), depending on the availability of complete data on 
the measures that were used (and the choice to use data imputation for missing data or not).  
 
2. Leiden Samples  
The two final research questions were investigated in studies using cross-sectional designs. 
Two samples of (mostly) undergraduate students at Leiden University were recruited. The key 
objectives of these studies were to obtain greater insight into the cognitive profiles of 




weaknesses and psychological or behaviour problems, and to find out whether chances of 
psychological or behaviour problems among cannabis users were influenced by the presence 
of cognitive weaknesses. Participants were classified as cannabis users when they reported 
using cannabis at least three times a month during the past year (they had not used cannabis 
24 hours prior to testing) and as non-users when they reported the use of cannabis 0 times in 
the past year and less than 4 times in their lifetimes. Based on these criteria, cannabis users 
and non-users were recruited at two points in time (2009 and 2010). In 2009 (Wave 1), 53 
cannabis users (mean age of 22.6) and 48 non-users (mean age of 22.3) were recruited. In  
2010 (Wave 2), 75 cannabis users (mean age 24.6 years) and 75 non-users (mean age 24.7 
years) were recruited. Participants were asked to volunteer in a study into information 
processing and social functioning of cannabis users. All participants signed informed consent 
forms.  
After participants agreed to enroll in the study, an appointment was made, where participants 
completed (social) cognitive tasks on a computer. Furthermore, they were asked to fill out 






Outline of the thesis 
The first focus of this thesis is on associations between cannabis use and behaviour problems. 
The second focus is on cannabis use and cognitive outcomes. In Chapter 2, we examine 
associations between cannabis use and mental health. Specifically, we focused on 
internalizing behaviour problems (withdrawn behaviour, somatic complaints and depression) 
and externalizing behaviour problems (delinquent and aggressive behaviour). First, we 
investigated whether cannabis use is related to both internalizing and externalizing behaviour 
problems in early adolescence. Next, path analysis was used to identify the temporal order of 
internalizing and externalizing problems and cannabis use, thereby testing the damage 
hypothesis, the self-medication hypothesis and the shared-causes hypothesis. In Chapter 3, we 
examine associations between cannabis use and vulnerability for psychosis during 
adolescence. Specifically, we focused on attention problems, thought problems and social 
problems as indicators of vulnerability for psychosis. Again, path analysis was used to 
identify the temporal order of cannabis use and vulnerability for psychosis, thereby testing the 
damage hypothesis, the self-medication hypothesis and the shared-causes hypothesis. In 
Chapter 4, we focus on social skills as possible risk factors of cannabis use. Specifically, we 
used multinomial regression analyses to find out whether the social skills of cooperation, 
assertiveness and self-control could predict cannabis use, early onset and frequency of use 
during early adolescence. In Chapter 5, we examine whether recreational cannabis users and 
non-users differed on motivational and cognitive inhibitory control. Also, we analysed 
possible relations between both types of inhibitory control and impulsive behaviour in 
everyday life. In Chapter 6, we examine social perception in cannabis users. We also tested 
whether (relatively) weak social perception would disproportionally increase the chances of 
cannabis users to experience psychological problems  (i.e. a variant of the vulnerability 
hypothesis). Finally, in Chapter 7, the main findings and conclusions of chapter 2-6 are 
presented and discussed. This thesis concludes with some implications for clinical practice 
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Aim: To examine the prospective relationship between externalizing and internalizing 
problems and cannabis use in early adolescence. 
Materials and Methods: Data were used from the TRAILS study, a longitudinal cohort 
study of (pre) adolescents (n = 1,449), with measurements at age 11.1 (T1), age 13.6 
(T2) and age 16.3 (T3). Internalizing (withdrawn behaviour, somatic complaints and 
depression) and externalizing (delinquent and aggressive behaviour) problems were 
assessed at all data waves, using the Youth Self Report. Participants reported on 
cannabis use at the second and third wave. Path analysis was used to identify the 
temporal order of internalizing and externalizing problems and cannabis use. 
Results: Path analysis showed no associations between cannabis use (T2-T3) and 
internalizing problems (T1-2-3). However, cannabis use and externalizing problems 
were associated (r ranged from .19–.58); path analysis showed that externalizing 
problems at T1 and T2 preceded cannabis use at T2 and T3, respectively. In contrast, 
cannabis use (T2) did not precede externalizing problems (T3). 
Conclusions: These results suggest that in early adolescence, there is no association 
between internalizing behaviour and cannabis use. There is an association between 
externalizing behaviour and cannabis use, and it appears that externalizing behaviour 





Regular cannabis use has been associated with a wide range of mental health 
problems including psychotic disorders (Arseneault et al., 2002; Moore et al., 2007), 
externalizing problems (aggressive and delinquent behaviour) (Fergusson et al., 2002; 
Monshouwer et al., 2006) and, to a lesser extent, internalizing problems, such as 
depression (Degenhardt et al., 2001; Degenhardt et al., 2003; Patton et al., 2002) and 
anxiety (Patton et al., 2002; van Laar et al., 2007; Hayatbakhsh et al., 2007a). Several 
hypotheses have been put forward to explain these associations, including the 
“damage hypothesis”, which proposes that cannabis use precedes mental health 
problems (Brook et al., 1998; Kandel et al., 1992) and the “self medication 
hypothesis”, which proposes that individuals with mental health problems tend to 
resort to drug use to sooth their problems (Khantzian, 1985). The “shared causes 
hypothesis” proposes that the linkage between cannabis use and mental health 
problems is the result of genetic and environmental factors associated with both 
problem behaviour and cannabis use (Fergusson and Horwood, 1997; Fergusson et 
al., 2002; Shelton et al., 2007). 
Shared causes are often found for externalizing behaviour and cannabis use 
(Fergusson and Horwood, 1997; Fergusson et al., 2002). Several studies have shown 
substantially weaker associations between cannabis use and externalizing behaviour 
after statistical control for factors such as socialeconomic status and use of other 
substances (e.g. Korhonen et al., 2010). However, most studies do show some 
residual variance in associations between externalizing behaviour and cannabis use 
that cannot be explained by environmental factors (Fergusson et al., 2007; Fergusson 
et al., 2002; Pedersen et al., 2001). The temporal order of cannabis use and both 
externalizing and internalizing behaviour has not yet been disentangled (Fergusson et 
al., 2002; Monshouwer et al., 2006). Most longitudinal evidence supports the self-
medication hypothesis, which states that externalizing problems precede the use of 
cannabis at this age (King et al., 2004; Fergusson et al., 2007; Pedersen et al., 2001). 
There is also evidence to suggest that externalizing behaviour during adolescence 
precedes cannabis use in early adulthood (Hayatbakhsh et al., 2007b). Although it is 
difficult to control for all potential confounders simultaneously, some of these studies 
did not control for important potential confounders, such as SES, use of other 




possibility of shared causes more than necessary. For internalizing behaviour, the 
relationship is evenmorecomplex: firstly, compared to externalizing behaviour 
problems, there is less evidence for an association between cannabis use and 
internalizing behaviour problems (Monshouwer et al., 2006). In several studies that 
did initially find a significant association between cannabis use and internalizing 
behaviour, the association became non-significant after statistical control for 
confounding variables (Harder et al., 2008; McGee et al., 2000). Nonetheless, there 
are some studies that have found evidence for the self-medication hypothesis, with 
internalizing behaviour problems preceding cannabis use at later age (King et al., 
2004; Wittchen et al., 2007). Again, shared causes cannot be ruled out, as the 
associations may be explained by residual confounding (Fergusson and Horwood, 
1997; Fergusson et al., 2002; Hayatbakhsh et al., 2007a). There is also (contrasting) 
evidence suggesting that internalizing behaviour in young adolescence is not related 
to substance use at a later age, including the use of cannabis (Alati et al., 2008; 
Hayatbakhsh et al., 2008; Ferdinand et al., 2001). Thus, in general, evidence 
regarding (the direction of) associations between cannabis use and internalizing/ 
externalizing behaviour problems in adolescence is not yet convincing, which is 
mainly due to the fact that most studies did not analyze temporally bi-directional 
associations (i.e., where cannabis use can precede but also follow behaviour 
problems), and which might also partly be due to the fact many studies did not control 
comprehensively for potentially confounding variables. 
It is important to study associations between externalizing and internalizing problems 
on the one hand and cannabis use on the other during early adolescence for several 
reasons. Firstly, early adolescence is a life phase characterized by rapid biological 
changes and consecutive maturation processes. These developmental processes might 
increase vulnerability for enduring effects of external influences like use of cannabis 
(Schneider, 2008). Secondly, cannabis use usually starts in early adolescence 
(Monshouwer et al., 2005), possibly because of increases in peer-influenced risk-
taking behaviours (e.g. Fergusson and Horwood, 1997). So this appears to be the best 
possible time to collect behavioural data antedating initiation of cannabis use. The 
study of associations between internalizing and externalizing behaviours and cannabis 
use during early adolescence may thus help identifying individuals who are at an 
increased risk for multiple simultaneous problems (e.g. aggression and substance use), 




might still help targeting one of the problems (preferably the one that occurs first in 
time) in order to prevent other or combined problems.  
In the present study, we investigated relations between both internalizing and 
externalizing behaviour problems and cannabis use in a large population sample of 
young adolescents enrolled in the Tracking Adolescents’ Individual Lives Survey 
(TRAILS, Huisman et al., 2008). Using path analysis, we investigated the temporal 
order of the association between cannabis use and internalizing and externalizing 
behaviour, thereby controlling for confounding factors to eliminate, to some extent, 
the effect of shared causes. It was expected that the link between internalizing 
behaviour and cannabis use would be weaker than the association between 
externalizing behaviour and cannabis use. In addition, based on findings to date, it 
was expected that internalizing and externalizing behaviour problems would precede 




Data were gathered from participants in the Tracking Adolescents’ Individual Lives 
Survey (TRAILS), a prospective cohort study among adolescents in the general Dutch 
population. TRAILS investigates the development of mental and physical health from 
preadolescence into adulthood (de Winter et al., 2005). The study covers biological, 
psychological and sociological topics and collects data from multiple informants. 
Participants come from five municipalities, including both urban and rural areas, in 
the North of the Netherlands. So far, three data collection waves have been 
completed: T1 (2001–2002), T2 (2003–2004) and T3 (2005–2007). Participants will 
be followed until (at least) the age of 24. Of all individuals asked to participate in 
TRAILS (N= 2935), 76,0% agreed to participate at T1 (N= 2230; mean age 11.09 
years; SD 0.55; 50.8% girls). At T2, 96.4% of these participants (N= 2149) were re-
assessed. T3 was completed with 81.4% of the original number of participants (N= 
1816), mean age 16.27 years; SD 0.73 (52.3% girls). At T3, 42 subjects were unable 
to participate in the study, due to mental/ physical health problems, death, emigration, 
detention or by being untraceable. With these subjects left out, response rate increases 
to 83.0%. More detailed information on the selection procedures and non-response 




(de Winter et al., 2005; Huisman et al., 2008). Analyses in the present study were 
based on 1.449 adolescents (53.3% girls, 46.7% boys) with non-missing data on all 




Cannabis use was assessed at T2 and T3 by self-report questionnaires filled out at 
school, supervised by TRAILS assistants. Confidentiality of the study was 
emphasized so that adolescents were reassured that their parents or teachers would not 
have access to the information they provided. Among others, participants were asked 
about lifetime use and use in the last year with the following questions: ‘How often 
have you used cannabis in your life/in the last year’, with answer categories: ‘I have 
never used’, ‘used it once’, ‘used it twice’, ‘three times’,......, ‘10 times’, ‘11–19 
times’, ‘20–39’ times, ‘40 times or more’). Items were recoded into five categories; 
(1) those who had never used; (2) those who had used but not during the past year 
(discontinued use); (3) those who used once or twice during the past year 
(experimental use); (4) those who reported using cannabis between 3 and 39 times 
during the past year (regular use); and (5) thosewhoreported using it 40 times or more 
during the last year (heavy use). The construction of these categories was similar to 
that used in other studies investigating cannabis use and mental health in young 
adolescents (e.g. Monshouwer et al., 2006). 
  
Behaviour problems 
Internalizing and externalizing behaviour were assessed with the Youth Self Report 
(YSR), which is one of the most commonly used self report questionnaires in current 
child and adolescent psychiatric research (Achenbach, 1991; Verhulst and 
Achenbach, 1995). The YSR contains 112 items on behavioural and emotional 
problems in the past 6months. Participants can rate the items as being not true (0), 
somewhat or sometimes true (1), or very or often true (2). The YSR covers the 
following domains: anxious/depressed, withdrawn/depressed, somatic complaints, 
social problems, thought problems, attention (hyperactivity) problems, aggressive 
behaviour, and rule-breaking behaviour. For the present study, we used two broad-
band dimensions of the YSR (Achenbach, 1991): (a) internalizing problems, 








Since SES, use of other substances and parental psychopathology have been shown to 
be among the most important correlates of cannabis use and both internalizing and 
externalizing behaviour (Fergusson and Boden (2008)), it was examined whether 
these should be included in the path analyses. 
 
Socioeconomic Status (SES) 
Socioeconomic Status (SES) was assessed at T1 using a 5 point scale consisting of 
five variables: educational level (father/mother), occupation (father/mother), and 
family income. The internal consistency of this measure is satisfactory (Cronbach’s 
alpha 0.84; Veenstra et al., 2006). 
 
Parental psychopathology 
Parental psychopathology (i.e. depression, anxiety, substance abuse, antisocial 
behaviour, and psychosis) was measured by means of the Brief TRAILS Family 
History Interview (Ormel et al., 2005), administered at T1. Each syndrome was 
introduced by a vignette describing its main symptoms and followed by a series of 
questions to assess lifetime occurrence, professional treatment, and medication use. 
The scores for substance abuse and antisocial behaviour were used to construct a 
familial vulnerability index for externalizing disorder. The scores for depression and 
anxiety disorder were used to construct an index for internalizing disorder. The 
construction of a familial vulnerability index was based on Kendler et al. (2003), who 
performed multivariate twin modelling to investigate shared genetic risk factors for 
psychiatric and substance use disorders. More information on the construction of 
familial vulnerability within TRAILS is described elsewhere (Veenstra et al., 2005). 
For both internalizing and externalizing disorder, parents were assigned to one of the 
following categories: (0) = (probably) not; (1) = (probably) yes, (2) = yes and 
treatment/medication (substance abuse, depression, and anxiety) or picked up by 






In order to assess alcohol and tobacco use, participants filled out a questionnaire at 
both T2 and T3 on the frequency of use in the past month. For tobacco use reported 
frequency was recoded into non-weekly (0) versus weekly (1), and for alcohol use, 
the reported frequency was recoded into non-monthly (0) versus monthly use (1). 
These categories were similar to those used in other studies investigating cannabis use 
and mental health in young adolescents (e.g. Monshouwer et al., 2006). 
 
Data analysis 
It was first examined whether non-responders differed from responders on SES (by 
means of t-test) and gender (by means of Pearson χ2-test). Next, it was examined 
whether, among the responders, there were differences between cannabis users and 
non-users with respect to SES, familial vulnerability for internalizing and 
externalizing behaviour, use of alcohol and tobacco and gender (using Pearson Chi-
square analysis for alcohol, tobacco use and gender and t-tests or GLMunivariate 
analysis of variance for SES and familial vulnerability). These analyses were 
performed in order to determine which variables should be included in the main 
analyses as covariates. The temporal order of occurrence of cannabis use and 
internalizing and externalizing behaviour was investigated using path analyses. In 
path analysis, an extension of the regression model, the regression weights predicted 
by the model are compared with the observed correlation matrix for the variables, and 
a goodness of fit statistic is calculated. The path coefficient is a standardized 
regression coefficient (beta) indicating the effect of an independent variable on a 
dependent variable in the path model. Thus, when the model has two or more 
independent variables, path coefficients are partial regression coefficients, which 
measure the extent of effect of one variable on another in the path model controlling 
for other variables, using standardized data or a correlation matrix. 
Following the two step approach recommended by Anderson and Gerbing (1988), 
confirmatory factor analysis (CFA) was used to investigate how well our 
hypothesized models fit the actual data. These models were based on previous 
research to assess temporal order of internalizing and externalizing behaviour (T1- 
T2-T3) and cannabis use (T2-T3) (e.g. Fergusson et al., 2002; McGee et al., 2000). 
In the path analyses, both internalizing and externalizing behaviour were introduced 




consisted of anxious/depressed, withdrawn/ depressed and somatic complaints. The 
latent variable ‘externalizing’ consisted of the indicators aggressive and delinquency. 
Cannabis use was represented by one indicator (i.e., the self-report measure consisting 
of the following categories: (1) those who had never used; (2) those who had used but 
not during the past year; (3) those who used once or twice during the past year; (4) 
those who reported using cannabis between 3 and 39 times during the past year; and 
(5) those who reported using it 40 times or more during the last year (see section 
2.2.1). Next, we modelled prospectively cannabis use and internalizing/ externalizing 
identified in the CFA. Here, we included all possible associations between latent 
variables. To evaluate overall model fit, the root mean square error of approximation 
was used (RMSEA; Steiger, 1998); a RMSEAvalue less than .05 (Browne and 
Cudeck, 1993) indicates good model fit. Both χ2 statistics and RMSEA are dependent 
on the size of the sample: as we had a relatively large sample (n = 1,449), we also 
used the comparative fit index (CFI; Bentler, 1990) to evaluate overall model fit. A 
CFI value greater than .90 (Bentler, 1990) indicates good model fit. All analyses were 




Responders (n = 1,449) and non-responders (n = 739) differed in terms of SES (t 
=−9.6, p < .001); responders scored higher on SES than non-responders (M= .07, SD 
= .78 vs. M=−.28, SD = .79). Responders also differed from non-responders in terms 
of gender (χ2 (1) = 10.5, p = .001: responders were more likely to be female (53.3%) 
than non-responders (46.1%). 
 
Descriptives 
Descriptive information regarding the frequency of cannabis use is presented in Table 
1 for participants with complete data on all variables of interest. The number of 
cannabis users increases with age as does the frequency of use. Cannabis users did not 
differ from non-users with respect to SES (t(1447) =−.9, p = .387), gender (χ2 (1) = 
1.1, p = .289), familial vulnerability for internalizing (t(1447) =−.4, p = .705) and 
externalizing behaviour (t(1447) =−1.8, p = .071). Cannabis users and non-users 




alcohol use at T3 (χ2 (1) = 95.0, p < .001), tobacco use at T2 (χ2 (1) = 137.3, p < 
.001) and tobacco use at T3 χ2 (1) = 346.8, p < .001), with cannabis users using 
alcohol and tobacco more often than non-users (57.8% vs. 31.2% reported monthly 
alcohol use at T2; percentages for T3: 94.0% vs. 70.7%; 19.8% vs. 2.2% reported 
weekly tobacco use at T2; percentages for T3: 57.4% vs. 11.1%). Tobacco and 
alcohol use were also related to both internalizing and externalizing behaviour and 
therefore included as covariates in subsequent path analysis (for detailed information, 
see Table 2). 
 
 
Table 1: Descriptive information on cannabis use at T2 and T3 (n=1,449) 
 T2  T3  
Never used 93.6 % (n=1359) 69.9 % (n=1013)  
Discontinued use 1.4 % (n=20) 5.9 % (n=86) 
Experimental use 3.7 % (n=54) 10.9 % (n=158) 
Regular use 1.2 % (n=17) 9.6 % (n=139) 





Table 2: t-statistics of significant control variables (tobacco use and alcohol use) and 
internalizing and externalizing behaviour 








T1 Internalizing behaviour -3.2* -1.6 -.2 1.0 
T2 Internalizing behaviour -3.7* -3.3* –.7 2.7* 
T3 Internalizing behaviour -4.2* -3.2* -.1 2.0 
T1 Externalizing behaviour -6.1* -5.4* -4.2* -3.1* 
T2 Externalizing behaviour -11.6* -11.3* -9.2* -3.4* 






Path analyses: Preliminary analyses 
Table 3 shows the correlations between all latent variables. Factor loadings of the 
indicators of the latent variables of internalizing behaviour and externalizing 
behaviour of all three measurement waves are presented in Table 4.  
 
Table 3: Correlations of all latent variables of the CFA 
 T2 Cannabis use T3 Cannabis use  
Model 1 
T1 Internalizing behaviour .06* -.04* 
T2 Internalizing behaviour .06* -.02* 
T3 Internalizing behaviour .05* .02* 
Model 2 
T1 Externalizing behaviour .19* .23* 
T2 Externalizing behaviour .40* .38* 
T3 Externalizing behaviour .24* .58* 
* p<.05 
 
Model 1. Cannabis use and internalizing behaviour problems 
The independence model testing the hypothesis that all cannabis scores and 
internalizing behaviour scores were uncorrelated was rejected: χ2 (30, N= 1,449) = 
56.4, p < .003. The model provided an acceptable fit to the data (CFI = .99, RMSEA 
= .03). However, as shown in Table 3, correlations between internalizing behaviour 
problems (T1-2-3) and cannabis use (T2-T3) ranged from .02 to .06 and thus are very 
small. Although these correlations were significant (probably due to the large sample 
size), they were indicative of non-relationships between cannabis use and 
internalizing behaviour. This was confirmed by the Wald test. Dropping parameters 
indicative of associations between internalizing behaviour (T1, T2 and T3) and 
cannabis use (T2 and T3) resulted in a non-significant change of the model [χ2 (6, 
N= 1,449) = 11.2, p = .081]. Path-analysis revealed that although our model 
represented the data well [χ2 (66,N= 1,449) = 215.2, p < .001; RMSEA = .04, CFI = 






Table 4: Factor loadings of the Indicators of the Latent variables of internalizing and 






Internalizing behaviour and cannabis 
T1 Internalizing behaviour  
     Anxious/Depressed .24 
     Withdrawn/Depressed .21* 
     Somatic complaints .17* 
T2 Internalizing behaviour  
     Anxious/Depressed .27* 
     Withdrawn/Depressed .21* 
     Somatic complaints .15* 
T2 Cannabis use  
     Cannabis use 1.00 
T3 Internalizing behaviour  
     Anxious/Depressed .26* 
     Withdrawn/Depressed .23* 
     Somatic complaints .16* 
T3 Cannabis use  
     Cannabis use 1.00 
 
Externalizing behaviour and cannabis 
T1 Externalizing behaviour  
     Aggressive behaviour 1.00 
     Rule-breaking behaviour .90* 
T2 Externalizing behaviour  
     Aggressive behaviour 1.00* 
     Rule-breaking behaviour 1.38* 
T2 Cannabis use  
     Cannabis use 1.00 
T3 Externalizing behaviour  
     Aggressive behaviour 1.00 
     Rule-breaking behaviour 1.67* 
T3 Cannabis use  







Model 2. Cannabis use and externalizing behaviour problems 
The independence model that tested the hypothesis that all cannabis scores and 
externalizing behaviour scores were uncorrelated, was rejected: χ2 (9, N= 1,449) = 
64.4, p < .001. Also, although RMSEA was relatively high (.07), the CFI was .99 and 
therefore our model provided an acceptable fit to the data. Correlations between 
externalizing behaviour (T1-2-3) and cannabis use (T2-T3) ranged from .19 to .58 and 
thus were indicative of a relationship between externalizing behaviour problems and 
cannabis use (see Table 4). Next, path analysis was performed to address the temporal 
order of cannabis use and externalizing behaviour problems (Fig. 1), hereby 
controlling for alcohol and tobacco use at T2 and T3.  
Path analysis revealed that the model represented the data well [χ2 (34,N= 1,449) = 
270.2, p < .001; RMSEA = .07, CFI = .96]. The paths between externalizing 
behaviour problems measured at T1, T2, and T3 were all significant (T1-T2; z = 11.8, 
p < .05; T1-T3; z = 4.9, p < .05; T2-T3; z = 11.5, p < .05). The path between cannabis 
use T2 and T3 was also significant (z = 5.4, p < .05). In addition, the paths between 
externalizing behaviour and tobacco use were all significant (T2; z = 11.7, p < .05; 
T3; z = 16.9, p < .05). Also, the paths between externalizing behaviour and alcohol 
use were all significant (T2; z = 8.4, p < .05; T3; z = 6.6, p < .05). The same occurred 
with cannabis use, where the paths between cannabis use and tobacco use were 
significant at T2 (z = 17.8, p < .05) and T3 (z = 18.0, p < .05) and also with alcohol 
use at T2 (z = 2.9, p < .05) and T3 (z = 5.7, p < .05). Moreover, externalizing 
behaviour and cannabis use significantly correlated at T2 (r = 0.19, p < .05) and T3 (r 
= 0.34, p < .05). 
Externalizing behaviour at T1 significantly predicted cannabis use at T2 (z = 3.8, p < 
.05) and T3 (z = 2.7, p < .05). Externalizing behaviour at T2 also significantly 
predicted cannabis use at T3 (z = 4.0, p < .05). Cannabis use measured at T2 did not 
show significant association with externalizing behaviour problems at T3 (z =−1.4, p 










Figure 1: Path analysis of externalizing behaviour, with indicators aggressive behaviour and 
rule breaking behaviour, and cannabis use in young adolescence after controlling for tobacco 
and alcohol use, measured at both T2 and T3. All non-significant paths have been removed 









In the present longitudinal study, 1,449 respondents were followed from the age of 11 
to 16 to assess the relationship between both internalizing and externalizing problems 
and cannabis use. Two different hypotheses, the damage hypothesis and the self-
medication hypothesis, were tested using path analyses, thereby controlling for 
possible confounding factors. 
First, our data showed that cannabis use is strongly related to externalizing behaviour 
problems in early adolescence, including aggressive and delinquent behaviour. This 
result is largely in agreement with previous studies (Fergusson et al., 2007; Fergusson 
et al., 2002; Khantzian, 1985; Monshouwer et al., 2006). As expected, our data 
supported the self-medication hypothesis, indicating that externalizing problems 
precede cannabis use during adolescence and not the other way around. Specifically, 
in our study, externalizing problems at age 11 were associated with cannabis use at 
age 13 and age 16. Also, externalizing behaviour at age 13 predicted cannabis use at 
age 16. 
These results are in agreement with a number of other studies. King et al. (2004), for 
example, also showed that externalizing psychopathology at age 11 predicted 
cannabis use at age 14, although it did not take into account potential confounders, 
such as the use of other substances. Korhonen et al. (2010) recently showed that early 
onset of smoking predicts cannabis initiation, while controlling for co-occurring 
externalizing behaviour problems. Whereas Korhonen et al. (2010) focused 
specifically on whether time of smoking initiation was predictive of the onset of 
cannabis use, we focused on the temporal order of cannabis use and externalizing 
behaviour problems. Although this study therefore had a different focus compared to 
the present study, it does illustrate the importance of controlling for potentially 
confounding factors when investigating cannabis-behaviour associations (or of 
controlling for behaviour when studying associations between specific environmental 
factors and cannabis use). Another longitudinal study (spanning 25 years) that did 
control for confounding factors demonstrated that conduct disorders at even a younger 
age (7–9 years) were related to later substance use, including cannabis use (Fergusson 
et al., 2007). Also, Pedersen et al. (2001), confirmed that conduct disorder at a young 
age is strongly associated with cannabis use in young teenagers. All these studies 




For the present study as well as earlier studies, it should be noted that externalizing 
behaviour explained only part of the variance of cannabis use, indicating that other 
factors are also important correlates of cannabis use during adolescence. Examples of 
such factors may be substance using peers and family functioning (e.g. Coffey et al., 
2000; Fergusson and Horwood, 1997). In addition, considering the concurrent 
correlations of cannabis use and externalizing behaviour at different measurement 
points we cannot rule out reciprocal relations between the two, i.e. lagged associations 
remain possible (Fergusson et al., 2005). Nonetheless, some evidence is provided here 
that such lagged associations start with the presence of externalizing behaviour, as 
there was negligible cannabis use at T1, while there was externalizing behaviour at 
that time. 
Although evidence of damaging effects of cannabis has been provided in other studies 
(Kandel et al., 1986; Kandel et al., 1992), our study did not support this hypothesis. 
This could be due to the fact that the sample was quite young and had not been using 
cannabis for a long period of time. Indeed, studies providing evidence for damaging 
effects of cannabis observed these effects in young adulthood (Fergusson et al., 2002; 
White et al., 1999). Possibly, such effects will also become evident in our sample at a 
later stage. For now, however, it should be concluded that externalizing problems at 
age of 11 and 13 predict cannabis use at later ages.  
If the self-medication hypothesis is true, as the evidence suggests, it would be good to 
know in more detail which aspects of externalizing behaviour elicit the need for 
“medication”. One explanation could be that those who show externalizing problems 
at age 11 use cannabis to get rid of feelings of hostility or anger. If the temporal order 
is not the consequence of some form of self-medication, a possible explanation is that 
cannabis use is a form of sensation seeking behaviour, which has regularly been 
identified as a characteristic of externalizing behaviour (Huizink et al., 2006; 
Marsman et al., 2008; Raine, 1996). There may be several mediating factors 
explaining the temporal order with externalizing problems preceding cannabis use as 
well. Examples include exclusion from peer groups that show less experimental 
behaviour and inclusion in peer groups showing increased levels of experimental 
behaviour among individuals characterized by externalizing behaviours (Coffey et al., 
2000; Fergusson and Horwood, 1997). 
With respect to internalizing behaviour problems, our study did not confirm the 




(Degenhardt et al., 2001; Degenhardt et al., 2003; Patton et al., 2002; Hayatbakhsh et 
al., 2007a). It should be noted that generally the relations between cannabis use and 
internalizing behaviour have been weaker than those with externalizing behaviour, 
and that existing associations could often be accounted for by co-occurring risk 
factors such as sociodemographic factors and use of other substances (Moore et al., 
2007). Our results are in agreement with those studies not finding an association at all 
(Monshouwer et al., 2006; Harder et al., 2008; McGee et al., 2000). 
A possible explanation for these mixed results might be that studies that did find 
significant associations focused mainly on older individuals (Brook et al., 1998; 
Hayatbakhsh et al., 2007a; Patton et al., 2002; van Laar et al., 2007; Wittchen et al., 
2007), although there is evidence opposing this hypothesis as well (Hayatbakhsh et 
al., 2008). For example, Hayatbakhsh et al. (2007a) showed, using logistic regression 
analysis, that cannabis use at the age of 15 was associated with an increased risk for 
Anxiety and depression at the age of 21. One study providing compelling evidence in 
favor of the hypothesis was performed by Arseneault et al. (2002), who concluded 
that the association between cannabis use and depressive symptoms was age 
dependent, following findings showing that cannabis use at age 15 was not associated 
with depressive symptoms at age 26 while cannabis use at age 18 was. Hayatbakhsh 
et al. (2007a) suggested that the association is not only dependent on age, but also on 
duration and frequency; only those who already started cannabis use at age 15 and 
using it frequently until the age of 21 showed elevated levels of anxiety and 
depression in young adulthood. The fact that internalizing problems are more evident 
in late adolescence and young adulthood than in early adolescence may also play a 
significant role (Kessler et al., 2007). 
The present study has a number of limitations. One limitation is that mental health 
and cannabis use data were obtained from self-reports. Use of multiple informants, 
particularly concerning mental health, would have been preferable (Offord et al., 
1996). Despite the fact that previous studies have concluded that self-reporting on 
substance use is generally valid (Buchan et al., 2002) (and the fact that cannabis use 
in The Netherlands is not illegal, which possibly allows more honest answers), one 
could still argue that the nature of the questions might have led to socially-desirable 
answers (especially for young adolescents). Another limitation is the loss of 
respondents between measurement 1 and 3, especially since non-responders differed 




responders would have been included in the present analysis, the present results 
would have strengthened, since it can be presumed that more cannabis users would be 
present among the non-responders. On the other hand, it can also be argued that the 
present results would have been weakened when non-responders (with lower SES) 
would have been included in the present analysis. SES could have explained a greater 
part of the variance of cannabis use, which in turn could have weakened the variance 
explained by externalizing behaviour. Lastly, despite the fact that we controlled for 
several important confounders, it cannot be ruled out that our results can be explained 
by non-observed confounding factors (thus supporting the shared causes hypothesis). 
For example, it has been shown that genetic factors are important determinants of 
both externalizing behaviour problems and cannabis use (Kendler et al., 2000; 
Lynskey et al., 2002; Rutter et al., 1999). Research using twin designs has also 
identified common genetic factors of externalizing problems and substance use 
behaviour during adolescence (Shelton et al., 2007; Young et al., 2000). For this 
study, we only had proxy variables of genetic confounding available (i.e. those 
constituting familial risk of internalizing and externalizing behaviour as well as 
substance use). There are also several environmental factors (e.g. family functioning, 
peer group influences) that could not be incorporated in this study. 
Despite some clear limitations, it may be noted that this study is one of the few 
prospective studies focusing on cannabis use and both internalizing and externalizing 
problems that was able to incorporate data assessed before cannabis initiation, 
allowing testing of both the damage and the self-medication hypotheses. Whereas 
externalizing problems at age 11 and 13 preceded cannabis use at age 13 and 16, 
cannabis use did not precede externalizing problems at any age. Future research 
should focus on a broader age span and use longer follow-up periods to investigate 
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Aims: To examine the direction of the longitudinal association between vulnerability 
for psychosis and cannabis use throughout adolescence.  
Design: Cross-lagged path analysis was used to identify the temporal order of 
vulnerability for psychosis and cannabis use, while controlling for gender, family 
psychopathology, alcohol use and tobacco use. 
Setting: A large prospective population study of Dutch adolescents [the TRacking 
Adolescents' Individual Lives Survey (TRAILS) study]. 
Participants: A total of 2,120 adolescents with assessments at (mean) age 13.6, age 
16.3 and age 19.1. 
Measurements: Vulnerability for psychosis at the three assessment points was 
represented by latent factors derived from scores on three scales of the Youth Self 
Report and the Adult Self Report, i.e. Thought Problems, Social Problems and 
Attention Problems. Participants self- reported on cannabis use during the past year at 
all three waves. 
Findings: Significant associations (r=.12-.23) were observed between psychosis 
vulnerability and cannabis use at all assessments. Also, cannabis use at age 16 
predicted psychosis vulnerability at age 19 (z=2.6, p<.05). Furthermore, psychosis 
vulnerability at ages 13 (z=2.0, p<.05) and 16  (z=3.0, p<.05) predicted cannabis use 
at, respectively, ages 16 and 19.  
Conclusions: Cannabis use predicts psychosis vulnerability in adolescents, and vice 







Epidemiological research has provided extensive evidence of associations between 
cannabis use and psychosis (Arsenault et al., 2002; Compton et al., 2009; Fergusson 
et al., 2003, Henquet et al., 2005; Kuepper et al., 2011; Manrique-Garcia et al., 2012; 
Moore et al., 2007; Rössler et al., 2012; Van Gastel et al., 2011). Cannabis use has 
been associated with both subclinical psychotic experiences and clinical psychotic 
disorder. However, the direction of the (temporal) associations between cannabis use 
and psychotic symptoms has not yet been fully explained. Several hypotheses 
considering the direction of the effect have been proposed. There is evidence for a so-
called ‘self medication hypothesis’, where individuals are hypothesized to use 
cannabis in order to alleviate their psychotic symptoms or to improve their mood 
(Khantzian, 1997; Kolliakou et al., 2011). There is more evidence, however, 
supporting an association in the opposite direction. This is referred to as the damage 
hypothesis, where cannabis use causes or exacerbates psychotic symptoms (Fergusson 
et al., 2003; Kuepper et al., 2011; Moore et al., 2006). Finally, there are some 
longitudinal studies suggesting a bidirectional relationship between cannabis use and 
psychotic experiences or symptoms (Moore et al., 2007; Ferdinand et al., 2005). 
Neurobiological studies have suggested that cannabis can indeed induce psychotic 
experiences when excessive Δ-9-tetrahydrocannabinol (Δ9-THC-) stimulation of 
cannabinoid (CB1-) receptors on GABAergic and glutaminergic terminals causes 
disruptions in dopaminergic projections from the brain stem to the striatum 
(Bhattacharyya et al., 2010; Morrison et al., 2009). It has also been proposed that the 
normally transient effects of Δ9-THC on physiological control of the endogenous 
cannabinoid (CBD-) system over glutamate and GABA release may be more harmful 
during adolescence because of adverse effects on the ongoing rapid maturation of 
neural circuits (particularly prefrontal cortex) at that stage of life (Bossong & Niesink, 
2010; Schneider, 2008).  
Studies into longitudinal cannabis-psychosis associations have often linked cannabis 
use during adolescence to psychotic experiences or symptoms in adulthood. 
Considering the rapid maturation of brain regions and neurotransmitter systems 
associated with both psychosis and cannabis exposure, and subsequent increased 
vulnerability (Bossong & Niesink, 2010; Schneider, 2008), however, it is important to 




relationships. There are several other arguments for investigating the associations 
within adolescence itself. One is that psychosis proneness is often already evident 
during early adolescence, which may not be surprising considering its strong heritable 
component (Gill et al., 2010; Rijsdijk et al., 2011). Although there may not yet be 
very obvious manifestations at this stage, there are proxy measures including specific 
cognitive, social, and thought problems which appear to be good predictors of later 
subclinical or clinical psychosis (Bearden et al., 2000; Tarbox & Pogue-Geile., 2008; 
Welham et al., 2009; Wigman et al., 2009). Moreover, there is increasing evidence for 
stability or continuity (from adolescence onwards) of psychosis symptoms (Poulton et 
al., 2000; Wigman et al., 2011; Yung et al.,  2009). This parallels the continuity (and 
sometimes transition into addiction and/or use of heavier drugs) observed for cannabis 
use Fergusson et al., 2006). Further evidence supporting a focus on (early) 
adolescence itself stems from studies showing that those who initiated cannabis use 
earlier and/or used cannabis for longer periods of time carried a greater risk for 
schizophrenia outcomes and psychotic experiences than those who initiated cannabis 
use later and/or used cannabis for shorter periods of time (Arsneault et al., 2002; 
Large et al., 2011; Schubart et al., 2010; Stefanis & van Os., 2004). Thus, in order to 
facilitate early recognition of psychosis (symptoms) and for a better understanding of 
the role of cannabis use in its development, research on their interrelations needs to 
incorporate important developmental stages including the entire period of 
adolescence.  
The present study focused on the direction of temporal relationships between cannabis 
use and vulnerability for psychosis in a large population sample of adolescents 
(n=2,120) enrolled in the TRacking Adolescents’ Individual Lives Survey (TRAILS) 
(Huisman et al., 2008), controlling for possible confounding variables such as SES, 
parental psychopathology and use of other substances. Assessment of both psychotic 
vulnerability and cannabis use at multiple time points allowed testing of both the self-







Data was gathered from participants in the TRacking Adolescents’ Individual Lives 
Survey (TRAILS), an on-going prospective population study of Dutch adolescents 
investigated biennially until at least the age of 25 years.  
The TRAILS target sample consisted of young adolescents from five municipalities in 
the north of the Netherlands, including both urban and rural areas. The sample 
selection involved two steps. First, the municipalities were requested to provide 
names and addresses of all inhabitants born between 10 January 1989 and 30 
September 1990 (first two municipalities) or between 10 January 1990 and 30 
September 1991 (last three municipalities), which yielded 3483 names. 
Simultaneously, primary schools (including schools for special education) within 
these municipalities were approached with a request to participate. School 
participation was a prerequisite for eligible adolescents and their parents to be 
approached by TRAILS, with the exception of adolescents who already attended 
secondary schools (<1%), who were contacted without involving their schools. Of the 
135 primary schools within the municipalities, 122 (90.4%) schools agreed to 
participate, accommodating 90.3% of the adolescents.  
Secondly, if schools agreed to participate, parents (or guardians) received two 
brochures, one for themselves and one for their adolescents, with information about 
the study. In addition, a TRAILS staff member visited the schools to inform eligible 
adolescents about the study. More details about the procedure have been published 
elsewhere (Huisman et al., 2008; de Winter et al., 2005). 
The exclusion criteria were: (1) adolescent’s inability of participating because of 
intellectual disability or a serious physical illness or handicap; (2) Dutch-speaking 
parent or parent surrogate not available, and not feasible to administer a part of the 
measurements in parent’s own language. Of all subjects who were approached 
(n=3145), 6.7% were excluded.  
Of the remaining 2935 young adolescents, 76.0% were included in the study (T1: n= 
2,230, mean age: 11.1 years, SD: 0.6, 50.8% female). For the present study, data from 
the first assessment (T1, mean age: 11.09 years; SD: 0.55; 50.8% girls) only involved 
control variables. Main analyses were performed with data of T2 (mean age: 13.6; 









Cannabis use by the participants was measured at the second, third and fourth 
assessments by self-report items on cannabis use in the last year with the following 
questions: ‘How often have you used cannabis in your life/in the last year’, with 
answer categories: ‘I have never used’, ‘used it once’, ‘used it twice’, ‘three 
times’,......, ‘10 times’, ‘11–19 times’, ‘20–39’ times, ‘40 times or more’. Items were 
recoded into four categories; (1) no use; (2) 1-2 times during the past year, (3) 3-6 
times during the past year; (4) 7 times or more during the past year.  
Other studies focusing on cannabis use have recoded the above answer possibilities 
into the following categories: (1) those who had never used; (2) those who had used 
but not during the past year, (discontinued use); (3) those who used once or twice 
during the past year, (experimental use); (4) those who reported using cannabis 
between 3 and 39 times during the past year, (regular use); (5) those who reported 
using it 40 times or more during the last year (heavy use) (Griffith-Lendering et al., 
2011; Monshouwer et al., 2006). Whereas it is more customary to use these 
categories, cross-lagged path analysis requires linear variables. The more traditional 
categorization did not result in a linear variable or a variable that could be used as 
such. In order to obtain a variable/categorization that best approached linearity, 
Tukey’s transformation ladder was used (Tukey, 1977). According to Tukey, a 
variable can be interpreted as linear (with equal distances between categories) when a 
straight line results after plotting the logarithmic transformation of the variable 
against the raw data. Using categories no use (1), 1-2 times (2), 3-6 times (3), and 7 
times or more (4) resulted in the best Tukey solutions for T2, T3, and T4.  
 
Psychosis vulnerability  
Psychosis vulnerability was conceptualized as a latent factor, indicated by three 
subscales of the Youth Self-Report (YSR) at measurement waves T2 and T3, and the 
Adult Self-Report (ASR) at T4; the Thought Problems, Attention Problems and Social 
Problems scales. The YSR is one of the most commonly used self-report 




for ages 11-19 (Achenbach & Rescorla., 2001; Verhulst & Achenbach., 1995). The 
YSR contains 112 items on behavioural and emotional problems in the past 6 months 
that can be rated as being not true (0), somewhat or sometimes true (1), or very or 
often true (2). The ASR is the equivalent of the YSR for individuals aged 18-59, and 
includes many of the YSR items, including some extra items on transitions to 
adulthood (Achenbach & Rescorla., 2001). Attention Problems of both the YSR and 
the ASR include items such as ‘having trouble concentrating’. The Thought Problems 
Scales of the YSR and the ASR include 12 items such as ‘seeing things that other 
people do not see’. Following earlier work (Wigman et al., 2011), three items (on skin 
picking; storing up many things and sleeping less than other children) were excluded 
based on their low Spearman inter-item correlations with the other items, leaving nine 
items in this subscale. For consistency, these items were also excluded from the ASR. 
The Social Problems scale of the YSR includes 11 items such as ‘feeling lonely’ and 
‘not getting along with other boys and girls’. Since only 7 of the original 11 items of 
the Social Problems scale of the ASR were measured at T4, we have converted all 
measures of the YSR and ASR into z-scores in further analyses to account for 
potential biases. Internal consistency for all subscales of YSR and ASR, measured at 
T2-3-4, was acceptable (Cronbach’s α ranged between 0.62 – 0.84).  
 
Control variables 
Use of other substances  
Tobacco use was measured at T2, T3, and T4, where adolescents were asked about 
their use in the last month. Answers were recoded into non-weekly versus weekly 
tobacco use. Use of alcohol was also measured at T2, T3 and T4, where adolescents 
were asked about the frequency of alcohol use in the past month. Alcohol use was 
recoded into non-monthly versus monthly use. These categories (for both tobacco use 
and alcohol use) were similar to those used in other studies focusing on cannabis use 
and mental health (e.g. Monshouwer et al., 2006). 
 
Socioeconomic status (SES) 
SES was assessed at baseline (T1) using a 5-point scale consisting of five variables: 




internal consistency of this measure is good (Cronbach’s alpha 0.84) (Ormel et al., 
2005). 
Parental psychopathology  
Parental psychopathology, (i.e. depression, anxiety, substance abuse, antisocial 
behaviour, and psychosis) was measured by means of the Brief TRAILS Family 
History Interview (Ormel et al., 2005; Veenstra et al., 2005), administered at baseline 
(T1). The scores for substance abuse and antisocial behaviour were used to construct a 
familial vulnerability index for externalizing disorder. The scores for depression and 
anxiety disorder were used to construct an index for internalizing disorder. More 
information on the construction of familial vulnerability within TRAILS can be found 
elsewhere (Ormel et al., 2005; Veenstra et al., 2005).  
 
Data-analysis  
Around 50 % of the original sample (n=1123) had complete data on all variables of 
interest measured at various waves. Consequently, the results of ‘complete-case’ 
analyses could potentially be biased. Using the method of multiple imputation 
(Schafer., 1997; Schafer & Graham., 2002), where multiple versions of the dataset are 
produced, each containing its own set of imputed values, and parameter estimates for 
all imputed datasets are pooled for further statistical analyses, missing data at T2, T3 
and T4 were imputed. First, participants missing data on either ‘cannabis use’ or 
‘psychosis vulnerability’ at all three waves were deleted from the sample (n=110), 
before imputation was carried out. Fully Conditional Specification (FCS), an iterative 
Markov chain Monte Carlo (MCMC) method, which for each variable in the order 
specified in the variable list fits a univariate model using all other available variables 
in the model as predictors, was chosen for multiple imputation. Data from T1 were 
entered only as ‘predictor variables’ of missing data of T2, T3 and T4. These included 
SES, gender, parental psychopathology and YSR scales of Social Problems, 
Attentional Problems and Thought Problems. All abovementioned variables plus 
cannabis use from T2, T3, and T4 were included in the model as both predictors and 
imputed data.   
In order to determine which variables should be included in the main analyses as 
covariates, it was examined whether there were differences between cannabis users 
(those indicating having used cannabis at least once) and non-users with respect to 




The temporal order of occurrence of cannabis use and psychosis vulnerability was 
investigated using path analyses. Following the two-step approach recommended by 
Anderson and Gerbin (1988), confirmatory factor analysis (CFA) was first used to 
investigate how well our hypothesized models fit the actual data. The models were 
based on the notion that either vulnerability for psychosis predicted cannabis use or 
the other way around.  
Next, cannabis use and vulnerability for psychosis, identified in the CFA, were 
modelled prospectively. Here, we included all possible associations between latent 
variables and all significant control variables. To evaluate the overall model fit, the 
Root Mean Square error of approximation was used (RMSEA) (Steiger, 1988); a 
RMSEA value less than .05 indicates good model fit (Browne & Cudeck., 1993). 
Both χ2 statistics and RMSEA are dependent on the size of the sample: as we had a 
relatively large sample (n=2,120), we also used the Comparative Fit Index (CFI) 
(Bentler., 1990) to evaluate overall model fit. A CFI value greater than .90 indicates 
good model fit [43]. All analyses were performed using EQS 6.1 for Windows 





Cannabis users (n=940) did not differ from non-users (n = 1180) with respect to 
familial vulnerability for internalizing disorders (t(2,118)=-.1.8, p=.066). Cannabis 
users were more often boys than girls (54.9% vs. 43.6%; χ2(1)=26.9, p<.001), 
monthly alcohol users (54.0% vs. 29.2%; χ2(1)=133.9, p<.001 at T2; 89.5% vs. 
68.2%; χ2(1)=136.1, p<.001 at T3; 94.3% vs. 77.8%; χ2(1)=110.9, p< .001 at T4) and 
weekly tobacco users (16.2% vs. 3.1%; χ2(1)=109.5, p<.001  at T2; 57.9% vs. 18.0%; 
χ2(1)=363.2, p<.001 at T3; 54.0% vs. 29.2%; χ2(1)=133.9, p<.001 at T4). 
Furthermore, cannabis users and non-users differed significantly with respect to SES 
(t (2,118)=-3.0 p=.002) and familial vulnerability for externalizing disorders (t (2,118) 
= -2.3, p=.022), where cannabis users scored higher on familial vulnerability for 
externalizing disorders and SES than non users. Of these variables, SES was not 
related to indicators of psychosis vulnerability and therefore not introduced as a 




tobacco use were related to psychosis vulnerability and therefore included as 
covariates in subsequent path analyses.  
Descriptives  
Descriptive information regarding the frequency of cannabis use is presented in Table 
1.  
 
Table 1; Descriptive information on cannabis use during the past year T2, T3 and T4 
(n=2,120). 
 T2  T3 T4  
No use 94.2 % (n=1,997) 74.2 % (n=1,574) 65.3 % (n=1,385) 
1-2 times   3.0 % (n=63) 7.6 % (n=162) 10.7 % (n=227) 
3-6 times  1.5 % (n=32) 7.4 % (n=157) 8.1 % (n=171) 
7 times or more  1.3 % (n=28) 10.7 % (n=227) 15.8 % (n=336) 
 
Path analysis; Preliminary analysis (CFA) 
The independent model which tested the hypothesis that all cannabis scores and 
psychosis vulnerability were uncorrelated was rejected: χ2(33,N=2,120)=207.1, p=< 
.001; RMSEA=.05; CFI=.98. The model provided an acceptable fit to the data. Table 2 
shows the correlations between all latent variables. All correlations between psychosis 
vulnerability and cannabis use were significant (p=<.05). Also, correlations became 
stronger over time. 
 
Table 2. Correlations between cannabis use and the latent variables for psychosis 






Cannabis use  
T2 Vulnerability for psychosis  .12* .15* .12* 
T3 Vulnerability for psychosis .08* .17* .15* 
T4 Vulnerability for psychosis .07* .17* .23* 





Cannabis use and psychosis vulnerability  
Next, we performed a path analysis to address the temporal order of cannabis use and 
psychosis vulnerability, after including the following covariates: gender, familial 
vulnerability for externalizing disorders, alcohol (T2-3-4) and tobacco use (T2-3-4). 
Figure 1 presents details on the path analysis of psychosis vulnerability and cannabis 
use, including factor loadings and correlations. 
The model represented the data well χ2(146,N=2,120)=1214,5, p<.001; RMSEA=.06, 
CFI =.92. As expected, the stability paths between vulnerability for psychosis 
measured at T2, T3, and T4 were all significant (T2-T3; z=22.6, p<.05 and T3-T4; 
z=23.8, p<.05) and so were the stability paths for cannabis use at the three different 
assessment points (T2-T3; z=8.1, p<.05 and T3-T4; z=20.6, p<.05).Vulnerability for 
psychosis at T2 predicted cannabis use at T3 (z=2.0, p<.05). Similarly, vulnerability 
for psychosis at T3 predicted cannabis use at T4 (z=3.0, p<.05). Also, cannabis use 
measured at T3 significantly predicted psychosis vulnerability measured at T4 (z=2.6, 
p<.05). Lastly, cannabis use measured at T2 did not predict psychosis vulnerability 






Figure 1. Path analysis of psychosis vulnerability (Psych. Vuln.), with indicators: Thought 
Problems (TP), Social Problems (SP) and Attention Problems (AP) and cannabis use during 
adolescence after controlling for gender, parental psychopathology, tobacco (T2-3-4) and 
alcohol use (T2-3-4) (n=2,120). All non-significant paths have been removed from the full 






This study investigated the longitudinal and bidirectional relationship between 
cannabis use and vulnerability for psychosis, as indicated by thought problems, social 
problems and attention problems, in a sample of 2,120 adolescents from the Dutch 
general population. The directionality of the longitudinal association between 
cannabis use and vulnerability for psychosis was examined by testing two contrasting 
hypotheses, the damage hypothesis and the self-medication hypothesis, using path 
analyses and controlling for possible confounding factors.  
The results showed that throughout adolescence, vulnerability for psychosis was 
associated with cannabis use. When investigating the temporal order of this 
relationship, bidirectional associations became apparent. More specifically, cannabis 
use at age 16 predicted vulnerability for psychosis at age 19, but psychosis 
vulnerability at age 16 also predicted cannabis use at age 19. Moreover, psychosis 
vulnerability at age 13 predicted cannabis use at age 16. Cannabis use at age 13 did 
not predict vulnerability for psychosis at age 16, but this could be due to a lack of 
statistical power, since the number of adolescents that had actually used cannabis at 
T2 was quite small (n=123).  
It may be concluded that the results provide empirical support for both the damage 
and the self-medication hypothesis. Whereas evidence has been provided for apparent 
unidirectional associations in many earlier studies (Arsenault et al., 2002; Compton et 
al., 2009; Ferdinand et al., 2005; Fergusson et al., 2003, Henquet et al., 2005; 
Khantzian., 1997; Kolliakou et al., 2011; Kuepper et al., 2011; Manrique-Garcia et al., 
2012; Moore et al., 2007; Rössler et al., 2012; Van Gastel et al., 2011), not many 
studies have been able to include multiple measurement points and thus test 
bidirectional associations. Moreover, some very plausible explanations have been 
offered for why the temporal association would head one way or the other. With 
respect to self-medication, it has been specifically hypothesized that individuals with 
psychosis symptoms use cannabis to improve their mood or to control one’s feelings, 
boredom, social motives, improving sleep, anxiety and agitation, although some 
studies indicate that individuals with psychosis symptoms use cannabis for similar 
reasons as the general population as well, i.e. ‘to get high’, relax and have fun (Caspi 
et al., 2005; Khantzian., 1997; Kolliakou et al., 2011). With respect to the damage 




adolescence as a particularly vulnerable period for the effects of cannabis. Still, when 
studies have been able to include multiple measurement points, the existence of 
bidirectional associations generally becomes evident (Ferdinand et al., 2005). The 
results of the present study give rise to the thought that a cascading model would fit 
the temporal associations between cannabis use and psychosis vulnerability best, 
particularly because associations between cannabis use and psychosis vulnerability 
became stronger at later assessments. In order to be able to study this in more detail, 
different statistical approaches might have to be chosen and possible moderation 
effects should also be taken into account. There are several studies showing 
interactions between particular gene variants as well as environmental factors and 
cannabis use in the prediction of psychosis Caspi et al., 2005; Cougnard et al., 2007; 
Decoster et al., 2012; Henquet et al., 2008).  
Some limitations of the present study should be kept in mind when interpreting the 
results. Firstly, data of the present study are all based on self-report. Although clinical 
interviews for assessment of psychosis vulnerability and multiple informants would 
have been preferable, previous studies have concluded that both substance use 
behaviour and mild psychotic symptoms can be reliably investigated by self-report 
(Buchan et al., 2002). Another limitation is that, despite the fact that several important 
potential confounders have been taken into account, we cannot claim to have been all-
inclusive in this respect. Whereas this would be the case for most, if not all large 
cohort studies, it may be argued that the choice of potential confounders could have 
been more refined. For example, the genetic variation associated with psychosis 
vulnerability and substance use could manifest itself in (impairments in) certain 
(dopamine or serotonin-dependent) cognitive abilities that could have been assessed 
as well. A third possible limitation is that three scales of the Youth Self Report and 
Adult Self-Report were used as indicators of psychosis vulnerability. Although these 
scales were shown to be associated with psychosis (Bearden et al., 2000; Tarbox & 
Pogue-Geile., 2008; Welham et al., 2009; Wigman et al., 2009), and may be good 
indicators of early manifestations of psychosis that could develop into the clinical 
disorder, future studies may want to include instruments measuring psychosis 
symptoms more directly as well (Rössler et al., 2011). 
Strengths of the current study include its longitudinal design, which allowed for 




for psychosis. Second, the starting point of the TRAILS-study is early adolescence, 
which allowed investigation of (factors associated with) cannabis use and 
development of psychosis from an earlier and possibly more crucial age compared to 
most other studies. This is particularly important considering recent hypotheses 
stating that cannabis-induced psychosis may be a distortion of normal adolescent 
brain maturation (Bossong & Niesink., 2010). Thirdly, a number of important control 
variables were included in the analyses, including the use of other substances and 
parental psychopathology.  
In conclusion, the present study showed that cannabis use at age 16 predicted 
psychosis vulnerability at age 19, and psychosis vulnerability at age 13 and 16 
predicted cannabis use at, respectively, age 16 and 19, thereby providing evidence for 
both the damage-hypothesis and self-medication hypotheses. Prevention programs 
aimed at delaying and preventing transition from subclinical psychotic symptoms to 
clinical disorder should target the entire adolescent life phase and pay attention to 
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Social Skills as Precursors of Cannabis Use in Young Adolescents  
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Social skills (cooperation, assertion, and self-control) were assessed by teachers for a 
longitudinal cohort of (pre)adolescents, with measurements at average ages 11.1 
(baseline) and 16.3 years (follow-up). Prospective associations with participants’ self-
reported use of cannabis, (age of) onset of cannabis use, and frequency of use at 
follow-up were examined using multinomial logistic regression analyses. Teacher-
reported social skills predicted different aspects of cannabis use independent of better 
known factors such as presence of externalizing behaviour and use of other 
substances. The direction of associations depended on the type of social skill. Good 
cooperation skills during early adolescence were associated with a reduced risk of 
lifetime cannabis use and a reduced risk of using cannabis on a regular basis. On the 
other hand, assertion at age 11 increased the risk of lifetime cannabis use and of using 






Cannabis is the most widely used substance after tobacco and alcohol, with a 
particularly high prevalence among adolescents and young adults (European 
Monitoring Centre for Drugs and Drug Addiction, 2009; Substance Abuse and Mental 
Health Services Administration, 2009). Most cannabis users start consuming cannabis 
in early adolescence (Monshouwer, Smit, de Graff, van Os, & Vollebergh, 2005). 
Cannabis use during this life phase is associated with several problematic outcomes, 
such as use of other (illicit) drugs (Fergusson, Boden, & Horwood, 2006; Lynskey et 
al., 2003), educational problems (Lynskey & Hall, 2000), and deviant peer affiliations 
(Fergusson, Swain- Campbell, & Horwood, 2002). Because of these adverse 
outcomes, it seems crucial to identify risk factors associated with cannabis use during 
adolescence.  
Many correlates or risk factors of cannabis use during adolescence have already been 
identified, including demographic factors (e.g., low socioeconomic status [SES]), 
poor academic performance, early onset of tobacco and alcohol use, drug using peers, 
family problems, and externalizing behaviour (e.g., Fergusson, Horwood, & Ridder, 
2007; Griffith-Lendering, Huijbregts, Mooijaart, Vollebergh, & Swaab, 2011; 
Korhonen et al., 2010; von Sydow, Lieb, Pfister, Hofler, & Wittchen, 2002). 
Associations between social functioning and social skills, on one hand, and cannabis 
use, on the other, have not yet been extensively studied, despite the fact that cannabis 
use during adolescence generally takes place in social contexts such as at parties, in 
dancing clubs, or on the street. 
Some studies did investigate cannabis use in relation to specific social skills or 
aspects of social functioning, such as social self-control and self-esteem (Pokhrel, 
Sussman, Rohrbach, & Sun, 2007; Sussman, McCuller, & Dent, 2003). Lack of social 
self-control refers to one’s tendency to act without thinking (Tarter, 1988), especially 
in a social context. Here, the use of cannabis was associated with lack of social self-
control. Negative self-esteem has also been associated with cannabis use in 
adolescence (Veselska et al., 2009), although self-esteem is not necessarily a social 
skill but rather a personality factor. Relations between social skills and cannabis use 
have not always been straightforward. For example, some findings suggest that those 
who experiment with cannabis during adolescence are socially better adjusted and 




1990). In addition, Engels and Ter Bogt (2001) showed that adolescents who 
experiment with cannabis had stronger peer relationships and were more socially 
competent in their relationships with peers than abstainers. Veselska et al. (2009) also 
focused on social competence and showed that adolescents with higher levels of 
assertive behaviour were more likely to use cannabis. They hypothesized that more 
socially competent adolescents may find themselves in social contexts where 
exposure to cannabis is high. These social contexts make adolescents more prone to 
experiment with cannabis. These findings illustrate that adolescence is a 
developmental phase where social interactions with peers become more important and 
more complex (Spear, 2000). To unravel the complex relations between cannabis use 
and social skills in adolescence, it therefore appears especially relevant to 
discriminate between different types of social skills. From a preventive perspective, 
one might assume that further discrimination is required with respect to outcome 
variables as well. Whether or not someone has (ever) used cannabis should be 
distinguished from onset and frequency of cannabis use. Both age of onset and 
frequency of use constitute risk factors for the use of other, possibly more dangerous 
or more addictive drugs, including alcohol and hard drugs (Fergusson et al., 2006; 
Lynskey et al., 2003). 
It is important to focus on early adolescence when examining social risk factors of 
cannabis use for several reasons. First, (neurobiological) developmental processes at 
this age could constitute increased vulnerability for enduring effects of external 
influences such as cannabis use (Arsenault et al., 2002; Schneider, 2008). 
Furthermore, associations between cannabis use and poor outcomes (e.g., crime, 
suicidal behaviour, depression, other illicit drug use, deviant peer affiliations) appear 
to be age related, with (much) stronger associations in the youngest adolescents (14–
15; Fergusson et al., 2002). 
The purpose of this study was to investigate the possible relationship between 
multiple social skills (cooperation, assertion, and self-control) and different cannabis-
use-related outcomes (i.e., whether cannabis was (ever) used, age of cannabis use 
onset, and frequency of cannabis use) during adolescence. It was hypothesized that 
cooperation and self-control would be negatively related to cannabis use. Cooperative 
behaviour is inversely related to aggressive-disruptive behaviour (Tinoco, Lagares, 
Moreno, Tessier, & Schneider, 2009). Because cannabis use is positively related to 




including aggressive and rule-breaking behaviour, it was hypothesized that good 
cooperative skills would be associated with less aggressive and rule-breaking 
behaviour as well as less cannabis use. The hypothesis regarding self-control and 
cannabis use was based on the findings by Pokhrel et al. (2007) and Sussman et al. 
(2003). Based on findings and arguments by Veselska et al. (2009), it was further 
expected that higher levels of assertive behaviour would be associated with higher 
risks of using cannabis. It was further hypothesized that poor social skills would 
predict early onset and high frequency of cannabis use. The predictive value of social 
skills on different aspects of cannabis use was examined while controlling for a 
number of well-established correlates of cannabis use, including SES, use of other 
substances (alcohol and tobacco), parental psychopathology, and externalizing 
behaviour. Moreover, based on differences in prevalence of cannabis use and 
presence of correlates of cannabis use for boys and girls (Nationale Drug Monitor, 
2009; Substance Abuse and Mental Health Services Administration, 2009), 





The present study is part of the TRacking Adolescents’ Individual Lives Survey 
(TRAILS) study and uses data from the first (T1) and third (T3) assessments of 
TRAILS, which ran from 2001 to 2002, and from 2005 to 2007, respectively. A 
detailed description of the sampling procedure and methods is provided in De Winter 
et al. (2005) and Huisman et al. (2008). The study was approved by the (Dutch) 
Central Committee on Research Involving Human Subjects. Briefly, the TRAILS 
target sample involved all 10- to 11-year-old children living in five municipalities, 
including both urban and rural areas, in the northern part of the 
Netherlands. Of all individuals asked to participate in TRAILS (N=2,935), 76.0% 
agreed to participate at T1 (N=2,230; M age=11.09 years, SD=0.55; 50.8% girls). 
Responders and non-responders did not differ with respect to the prevalence of 
teacher-rated problem behaviour, sociodemographic variables, and health indicators 
(de Winter et al., 2005). T3 was completed with 81.4% of the original number of 




the present study were based on 1,363 adolescents (54.2% girls, 45.8% boys) with 
nonmissing data on all variables of interest (described next). This sample consisted of 
the following nationalities: 88.8% Dutch, .3% Turkish, .5% Moroccan, 1.5% 
Surinam, 1.2% Antillean, 1.5% Indonesian or Mollucan. The remaining 6.2% had 




Cannabis use by the participants was measured at T3 by four self-report items. The 
first question concerned the age of first cannabis use, with the following answer 
categories: never used, 9 years or younger, 10, 11, 12, 13 or 14, 15 or 16 years. In 
addition, participants were asked about lifetime use, use in the last year, and use in the 
last month with the following questions: ‘How often have you used cannabis in your 
life in the last year/ in the last month?’ with answer categories ‘I have never used,’ 
‘used it once,’ ‘used it twice,’ ‘three times,’ . . . ‘10 times,’’ ‘11–19 times,’ ‘20–39 
times,’ ‘40 times or more’). Those who reported using cannabis at least once during 
their lifetime were classified as cannabis users in the dichotomous variable used for 
the first set of analyses. For age of onset, items were recoded into three categories: (a) 
those who had never used, (b) those who used before the age of 15, and (c) those who 
used at age 15 or older. For frequency of use, items were recoded into five categories: 
(a) those who had never used, (b) those who had used but not during the past year 
(discontinued use), (c) those who used once or twice during the past year 
(experimental use), (d) those who reported using cannabis between 3 and 39 times 
during the past year (regular use), and (e) those who reported using it 40 times or 
more during the last year (heavy use). The construction of these categories was 
similar to that used in other studies focusing on cannabis use in the Netherlands 
(Griffith-Lendering et al., 2010; Monshouwer et al., 2006). 
 
Social skills 
Social skills of the participants were evaluated by teachers at T1. The Social Skills 
Rating System (SSRS; Gresham & Elliott, 1990) is a standardized questionnaire that 
evaluates children’s social skills and is appropriate for the age range of 3 to 18 years. 




Skills domain contains the subscales of Cooperation (10 items, α =.90), Assertion (10 
items, α =.88), and Self-Control (10 items, α =.91). The Cooperation subscale 
includes behaviours such as helping others and complying with rules and directions. 
The Assertion subscale includes initiating behaviours, such as asking others for 
information and introducing oneself. The Self-Control subscale includes behaviours 
that emerge in conflict situations such as appropriate management of teasing, and in 
non-conflict situations such as ‘taking turns’ and compromising. Teachers rated items 
on a 3-point scale: 1 (never), 2 (sometimes), and 3 (very often). For the SSRS–
Teacher form, Gresham and Elliot (1990) reported evidence for acceptable internal 
consistency, test–retest and interrater reliability, content validity, and criterion-related 
validity. In addition, van Oord et al. (2005) evaluated psychometric  properties of the 
Dutch translation of the SSRS and concluded that all SSRS scales had adequate 
internal consistency (all above .76). 
 
Socialeconomic Status (SES) 
The TRAILS database contains several variables contributing to an overall score for 
Socialeconomic Status (all measured at T1): income level, educational level of both 
the father and the mother, and occupational level of each parent, using the 
International Standard Classification for Occupations (Ganzeboom & Treiman, 1996). 
SES was operationalized as the standardized average of these five items 
(standardized). The internal consistency of this measure is satisfactory (Cronbach’s 
alpha=.84; Veenstra, Lindenberg, Oldehinkel, De Winter, & Ormel, 2006). 
 
Parental psychopathology 
Parental psychopathology (i.e., for depression, anxiety, substance abuse, and 
antisocial behaviour) was measured by means of the Brief TRAILS Family History 
Interview (Ormel et al., 2005), administered at T1. Each syndrome was introduced by 
a vignette describing its main symptoms and followed by a series of questions to 
assess lifetime occurrence, professional treatment, and medication use. The scores for 
substance abuse and antisocial behaviour were used to construct a familial 
vulnerability index for externalizing disorder. The scores for depression and anxiety 
disorder were used to construct an index for internalizing disorder. 




Myers, and Neale (2003), who performed multivariate twin modelling to investigate 
shared genetic risk factors for psychiatric and substance use disorders, and performed 
for TRAILS by Veenstra and colleagues (Veenstra et al., 2005). For both internalizing 
and externalizing disorder, parents were assigned to one of the following categories: 
(probably) not (0); (probably) yes (1); yes plus either the use of treatment=medication 
(for substance abuse, depression, and anxiety) or having been picked up by police 
(antisocial behaviour) (2).  
 
Externalizing behaviour problems 
Externalizing behaviour at T1 was assessed using the Youth Self Report (YSR), 
which is one of the most commonly used self-report questionnaires in current child 
and adolescent psychiatric research (Achenbach, 1991; Verhulst & Achenbach, 1995). 
The YSR contains 112 items on behavioural and emotional problems in the past 6 
months. Participants can rate the items as being not true (0), somewhat or sometimes 
true (1), or very or often true (2). For the present study, we used the Externalizing 
Behaviour Problems scale, which consists of items measuring aggressive and rule-
breaking behaviour (Achenbach, 1991). Reliability and validity of the Dutch version 
of the YSR have been shown to be satisfactory (de Groot, Koot, & Verhulst, 1996; 
Verhulst, van der Ende, & Koot, 1997). 
 
 
Use of other substances 
Alcohol use and tobacco use by the participants were measured at the third 
assessment. Participants self-reported on the frequency of use in the past month. For 
tobacco use reported frequency was recoded into nonweekly (0) versus weekly (1), 
and for alcohol use, the reported frequency was recoded into nonmonthly (0) versus 
monthly use (1). These categories were similar to those used in other studies focusing 
on cannabis use in the Netherlands 
(Monshouwer et al., 2006). 
 
Data Analyses 
It was first examined whether those with missing values on one or more variables of 
interest (n=453) differed from those without missing values (n=1,363) on SES (by 




investigated whether control variables should be included in the main statistical 
analyses as covariates (i.e., whether cannabis users differed from nonusers on these 
variables) using t tests or GLM univariate analysis of variance for SES, parental 
psychopathology, externalizing behaviour problems, and using Pearson chi-square 
analysis for gender, alcohol, and tobacco use. It was then tested whether these 
variables were related to social skills using Pearson correlation for SES, parental 
psychopathology, externalizing behaviour, and using t-tests or GLM univariate 
analysis of variance for gender, alcohol, and tobacco use. 
Logistic regression analysis was performed to examine the impact of social skills on 
whether or not cannabis was used during adolescence. Using multinomial regression 
analysis, onset of cannabis use was predicted by social skills using the three-category 
variable (a) no use (reference group), (b) early onset, and (c) late onset. Next, 
multinomial regression analyses were used to predict frequency of cannabis use at T3 
from social skills, using a five-category cannabis variable as the dependent variable: 
(a) those who had never used (reference group), (b) discontinued use, (c) 




Participants with and without missing values did not differ in terms of SES. 
Participants without missing values were more likely to be girls (54.2%) compared to 
those with missing values (46.6%): χ2 (1) =8.0, p=.005. In the sample used for further 
statistical analyses (n=1,363), cannabis users (n=400) did not differ from nonusers 
with respect to gender (χ2=.34, p=.561), SES (t=.97, p=.332), and familial 
vulnerability for internalizing behaviour (t=_-84, p=.404). Cannabis users and 
nonusers did, however, differ significantly on familial vulnerability for externalizing 
behaviour (t=-2.1, p=.037), externalizing behaviour (t=-6.4, p<.001), alcohol use 
(χ2=83.6, p<.001) and tobacco use (χ2=367.1, p<.001). Cannabis users scored higher 
on both familial vulnerability for externalizing behaviour (M=.2, SD=.4) and 
internalizing behaviour (M=.3, SD=.2) than nonusers (M=.1, SD=.4 and M=.2, 
SD=.2, respectively). In addition, cannabis users were more often monthly alcohol 
users (92.8% vs. 69.7%) and also more often weekly tobacco users than nonusers 




behaviour, tobacco use, and alcohol use were also related to social skills and therefore 
introduced as covariates in further statistical analyses (Table 1). 
 
Table 1: Correlation among variables 
 Control variables Teacher- Reported 
Social Skills 
Cannabis use variables  




































1. –          
2. .1* –          
3. .1** .28* –        
4. .0 .1** .2** –       
5. -.1** -.2** -.288 .0 –      
6. -.1** -.1** -.1** .1** .5** –     
7. -.1** -.2** -.1** .1 .7** .7** –    
8. .1* .2** .5** .3** -.2** .0 -.1** –   
9. .0 .1** .4** .2** -.2** .0 -.1** .9*8 –  
10. .1* .2** .5** .2** -.2** .0 -.1** .9** .8** – 
Note: n=  1,363.  
Fam Vuln Ext.=familial vulnerability externalizing behaviour;  
Ext. Beh = Externalizing Behaviour.  
* p<.05. **p<.01. 
 
Descriptives 
At follow-up (i.e., when participants had a mean age of 16.3 years), 71.1% had never 
used cannabis, 6.1% had used cannabis but not during the past year (discontinued 
use), 10.6% had used it once or twice during the past year (experimental use), 8.8% 
had used cannabis between 3 and 39 times during the past year (regular use), and 
3.4% had used it more than 39 times in the past year (heavy use). Forty-six percent 
(n=184) of users were ‘early starters,’ indicating onset of cannabis use before the age 
of 15; 54% (n=216) were ‘late starters,’ indicating onset of cannabis use at age 15 or 
older. 
 
Predicting Cannabis Use 
The impact of social skills (cooperation, assertion, and self-control) on cannabis use 




Tobacco use, alcohol use, and externalizing behaviour problems all increased the 
chance of cannabis use (Table 2). After adjusting for these control variables, logistic 
regression analyses revealed that at baseline, high levels of SSRS–Cooperation were 
associated with reduced chances of cannabis use during adolescence (odds ratio 
[OR]=.4; 95% confidence interval [CI] [.3, .6]; p<.001). High levels of SSRS–
Assertion were associated with increased chances of cannabis use (OR=1.8; 95% CI 
[1.1, 2.8]; p=.014; Table 2). No moderating effect of gender was found. 
 
Table 2. Summary of Logistic Regression Analysis Predicting Cannabis Use (n=1369). 
 B SE OR 
Covariates    
Familial vulnerability for externalizing behaviour 0.1   0.2 1.1 
Externalizing behaviour 1.0** 0.4 2.8 
Tobacco use 2.3*** 0.2 10.0 
Alcohol use 1.3*** 0.2 3.7 
Social Skills    
Cooperation -0.9 0.2 0.4 
Assertion  0.6 0.2 1.8 
Self control -0.2 0.2 0.8 
Constant -3.9   
χ2 24.9***   
df 7   
B = Unstandardized coefficient; SE = standard errors; OR = Odds Ratio. 
* = p < .05; ** = p < .01; *** = p < .001 
 
Predicting Age of Onset  
Multinomial regression analyses revealed that of the control variables, tobacco use 
and alcohol use were related to both early and late onset of cannabis use (Table 3), 
indicating a heightened risk for both early and late onset of cannabis use compared to 
nonuse. Externalizing behaviour problems, however, were associated only with early 
onset of cannabis use. After adjusting for externalizing behaviour problems, alcohol 
use, and tobacco use, cooperation predicted both early (OR=.4; 95% CI [.2, .7]; 
p=.001) and late (OR=.4; 95% CI [.3, .7], p=.002) onset compared to nonuse. 
Assertion also predicted both early (OR=1.9; 95% CI [1.0, 3.4], p=.041) and late 
(OR=1.7; 95% CI [1.0, 2.9]; p=.046) onset of cannabis use compared to nonuse 
(Table 3). Cooperation and assertion did not significantly discriminate between the 





Table 3. Summary of Multinomial Logistic Regression Analysis Predicting Early (9–14 
Years) and Late Onset (15–16 Years) of Cannabis Use. 
 Early Starters                Late Starters 
 B SE OR B SE OR 
Familial Vulnerability 
Ext.Beh. 












Externalizing Behaviour   1.7*** 0.5  5.7  0.5 0.5 1.7 
Tobacco Use   2.8*** 0.2 16.3  1.9*** 0.2 7.0 
Alcohol Use   1.4*** 0.3  4.0  1.3*** 0.3 3.6 
Cooperation  -1.0*** 0.3  0.4 -0.8** 0.3 0.4 
Assertion   0.6* 0.3  1.9 0.5* 0.3 1.7 
Self control   0.0 0.3  1.0 -0.3 0.3 0.7 
Constant  -6.1   -3.5   
χ2 457.5***      
df    14      
Note: n = 1,363. Reference category consists of subjects who did not report any cannabis use 
at T3. OR = odds ratio; Ext. Beh. = externalizing behaviour. 
*p < .05.  **p < .01.  ***p < .001. 
 
Predicting Frequency of Cannabis Use 
As the separate categories for discontinued and heavy use were considered to contain 
too few participants, these were merged with the ‘never used’ and ‘regular use’ 
categories, respectively. This resulted in the following categories for statistical 
analysis: (a) those who had never used and discontinued users, (b) experimental users, 
and (c) regular and heavy users. When predicting frequency of cannabis use by 
cooperation, assertion, and self-control, multinomial regression analyses showed that, 
of the control variables, tobacco use and alcohol use were related to both 
experimental use and regular use of cannabis, whereas externalizing behaviour 
problems was only related to regular/ heavy use of cannabis (Table 4). 
After controlling for family vulnerability for externalizing behaviour, externalizing 
behaviour problems, alcohol use, and tobacco use, high scores on cooperation 
predicted lower regular/heavy use (OR=.4; 95% CI [.2, .6], p=.001). Good 




user compared to being a nonuser. Chances of being an experimental user as opposed 
to a nonuser also reduced as a function of cooperative skills, although this effect just 
failed to reach significance. Assertion predicted higher experimental use (OR=2.1; 
95% CI [1.1, 3.7]; p=.021) as opposed to non-use. Thus, although cooperation did not 
predict regular use compared to experimental use, there are indications that good 
cooperative skills particularly prevent adolescents from becoming a regular or heavy 
user. Also, assertive skills only predicted experimental use, not regular or heavy use, 
which may also be important when social skills are considered intervention or 
prevention targets. Social skills and gender did not significantly interact. 
 
Table 4 Summary of Multinomial Logistic Regression Analysis Predicting Experimental and 
Regular/ Heavy Cannabis Use. 
 Experimental users                                      Regular /  Heavy users 
 B SE OR B SE OR 
Familial Vulnerability 
Ext. Beh. 
  -0.1 0.2  0.9 0.2 0.2 1.3 
Externalizing Behaviour   0.7 0.2  1.9  1.5** 0.5 4.3 
Tobacco Use   1.6*** 0.2  4.9  2.5** 0.2 11.8 
Alcohol Use   1.3*** 0.3  3.8  1.5** 0.4 4.6 
Cooperation  -0.5*** 0.3  0.6 -1.0** 0.3 0.4 
Assertion   -0.7* 0.3  2.0 0.5 0.3 1.1 
Self control   -0.4 0.3  2.7 -0.1 0.3 1.1 
Constant   4.8      
χ2 359.8***      
df    14      
Note: n=1,363. Reference category consists of subjects who did not report any cannabis use at 
T3. OR = odds ratio; Ext. Beh.= externalizing behaviour. 
*p<.05. **p<.01. ***p<.001. 
 
Discussion 
The present study examined multiple social skills as possible risk factors for cannabis 
use during adolescence. Those who had used cannabis by the age of 16 had lower 
levels of cooperation at age 11, compared to nonusers. Assertion was differently 
related to cannabis use; specifically, cannabis users were more assertive than 
nonusers. Cooperation includes behaviours such as helping others, complying with 
rules and directions, and sharing materials. Assertion involves behaviours such as 




others. Self-control was not related to cannabis use during adolescence. It is important 
to note that cooperation and assertion were predictive of cannabis use independent of 
other, better-known factors associated with cannabis use, such as use of other 
substances or externalizing behaviour. 
Social skills did not predict early versus late onset of cannabis use. Chances of both 
early and late onset decreased with higher levels of cooperation and increased with 
higher levels of assertion. Social skills did not predict regular/heavy use versus 
experimental use either, although high levels of cooperative behaviour particularly 
appeared to reduce the chances of being a regular/heavy user rather than a nonuser. 
Assertion particularly increased the chance of being an experimental user rather than 
a nonuser. This result could indicate that, although assertion increases the chance of 
cannabis use during adolescence, it does not do so for heavy cannabis use, which may 
be considered a risk factor for using other more addictive drugs (Fergusson et al., 
2006). Still, despite the fact that both cooperation and assertion are considered 
positive social skills, our results show that they are differentially predictive of what 
may be considered risky behaviour (i.e., becoming a cannabis user). Cooperative 
behaviour, as expressed in, for example, complying with rules and directions, reduces 
chances of risky behaviour, whereas the type of engagement represented by the 
assertion items appears to increase chances of risky behaviour. 
Our results are in line with expectations. Previous studies have shown negative 
associations between cooperative behaviour and aggressive/ disruptive behaviour 
during adolescence (Tinoco et al., 2009). Because cannabis use has been positively 
associated with aggressive and rule-breaking behaviour repeatedly (Fergusson et al., 
2002; Griffith-Lendering et al., 2010 Monshouwer et al., 2006), it was expected that 
cooperative behaviour would also be related to a reduction in chances of cannabis use. 
This is what our findings indicated. When focusing on assertive behaviour, Veselska 
et al., (2009) also showed that higher levels of assertion (or social competence) were 
associated with cannabis use among adolescents (M age=14.3 years). Veselska et al. 
argued that those adolescents with high levels of social competence (i.e., those who 
were more assertive) are more likely to find themselves in places where exposure to 
drug (cannabis) use is high, thereby providing a social context for cannabis use. One 
can also argue that assertive adolescents are inclined to enter new social situations 
more frequently; in other words, they are less inhibited and therefore show more risk-




Our data did not confirm the social skill of self-control to be related to cannabis use, 
age of onset, or frequency of use. This appears to be inconsistent with previous 
studies focusing on self-control and cannabis use (Pokhrel et al., 2007; Sussman et al., 
2003). This discrepancy in findings may be explained by different operationalizations 
of the construct self-control or by assessment through different informants. Although 
self-control refers to one’s tendency to act without thinking (Tarter, 1988), social self-
control is a self-control measure related to interpersonal relations. In addition, in this 
study, self-control, defined by the SSRS as ‘behaviours that emerge in conflict and 
non-conflict situations’ was rated by the participants’ teachers. Whereas assertion and 
cooperative behaviour may be behaviours that occur frequently in (generally well-
structured) classroom settings, self-control items may be more difficult to observe and 
rate in this context.  
Strengths of this study are its prospective design and its large population. Also, this is 
one in a few studies that focused on different social skills rather than general social 
ability, which could have masked the differential effects of different social skills. 
Furthermore, this study focused on different cannabis use variables (i.e., cannabis use, 
age of onset, and frequency of use). A possible limitation of the study is that 
participants self-reported on cannabis use. Although previous studies have concluded 
that self-reporting on substance use is generally valid (Buchan, Dennis, Tims, & 
Diamond, 2002), one can still argue that the nature of the questions could have led to 
socially desirable answers (especially for young adolescents). Another limitation is 
the loss of respondents between baseline and follow-up. Furthermore, the reliability of 
the measurement of social skills could have benefited from the use of multiple 
informants (i.e., parents=caretakers as well as teachers). This could have covered 
social skills in different contexts. Also, because of the liberal laws regarding cannabis 
use in the Netherlands, it is unclear whether the results of the present study are 
applicable across countries. Despite these differences in laws, the percentage of young 
adults using cannabis in the Netherlands is similar to that in other European countries 
(European Monitoring Centre for Drugs and Drug Addiction, 2009) and the United 
States (Substance abuse and mental health services administration, 2008). 
 
The general conclusion of this study is that different teacher-reported social skills are 
differentially predictive of cannabis use during early adolescence and that these 




social behaviour. Good cooperative skills decreased the chance of cannabis use, 
whereas high levels of assertion increased the probability of (experimental) cannabis 
use. 
The results of this study show that social functioning might deserve more attention in 
studies investigating precursors of substance use and abuse. In the present study, we 
focused on social skills, but other aspects of social functioning may also be of 
importance. Examples include functioning and roles within peer groups and quality of 
other interpersonal relations. The presence of psychopathology or, for example, 
externalizing behaviour in high but subclinical gradations may be stronger predictors 
of substance use and, possibly, the transition into addiction. However, there appears 
to be a role for social functioning in general as well. The extent to which different 
aspects of social functioning contribute to substance use and addiction should be 
clarified further, both their unique contribution and their contribution in combination 
with other risk factors, such as psychopathology, but also poor sociodemographic 
circumstances. 
In social skills interventions, it should be taken into account that specific social skills 
are not by definition, or under all circumstances, ‘‘good’’ or ‘‘bad.’’ A more subtle 
approach appears to be required. For example, it seems unlikely that suppressing 
assertive behaviour would be beneficial. Still, the positive associations between 
assertive behaviour and cannabis use suggest something could be done with this type 
of behaviour. Possibly, the focus regarding this behaviour should lie on stimulating 
assertive refusal behaviour (Botvin, 2000; Botvin & Griffin, 2007). Whereas the 
findings regarding cooperative behaviour appear to be relatively straightforward, it 
might be important here as well to not stimulate every form of cooperative behaviour. 
Moreover, it may be important to take into account individual goals. That is, if 
someone is cooperative to fit within certain peer groups (which could or could not be 
a group involved in substance use), it may be beneficial to target contextual factors, 
emphasizing situations during which cooperative behaviour should or should not be 
shown. One can also imagine that certain forms of assertive behaviour can actually 
help decision making in such situations. Thus, the important point is that positive 
results regarding the prevention of cannabis use or the transition into addiction could 
be obtained not by suppressing or stimulating particular types of social behaviour, but 
by considering the different forms of certain social behaviours in different contexts 
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Substance use disorders have been associated with impaired decision-making and 
increased impulsive behaviour. Lack of inhibitory control may underlie such higher-
order cognitive difficulties and behaviour problems. This study examined inhibitory 
control in 53 recreational cannabis users and 48 controls. Inhibitory control was tested 
with two computer tasks, one with a motivational component and one without such a 
component. Impulsive behaviour was assessed using the Barratt Impulsiveness Scale. 
Results showed that the recreational cannabis users had poorer motivational inhibition 
(i.e. were more inclined to ‘gamble’) than controls. There were no group differences 
in the cognitive inhibition task. Cannabis users also reported more impulsive 
behaviour in daily life. This behaviour was related to response style in the 
motivational inhibition task, but not to performance in the cognitive inhibition task. It 
is concluded that, among recreational cannabis users, lack of inhibitory control 
depends on contextual or situational factors, i.e. it becomes evident only when 







Cannabis abusers share a considerable number of neuropsychological weaknesses 
with abusers of other drugs such as psychostimulants, opoids and alcohol (and with 
polysubstance abusers) (Fernández-Serrano, Pérez-García, & Verdejo-García, 2011). 
These include impairments in episodic memory, emotional processing, implicit 
cognition and executive function (EF). Although there is evidence suggesting some 
more specific deficits as well, including those regarding prospective memory, 
processing speed, and complex planning, there are generally abusers of other 
substances showing these deficits as well (Fernández-Serrano et al., 2011; Grant, 
Gonzalez, Carey, Natarajan, & Wolfson, 2003; Piechatzek et al., 2009). Many studies 
have employed tasks or investigated psychological constructs that appear to be built 
up of multiple, more basic components. One such component is inhibitory control. 
Next to deficits in memory and processing speed, the most consistently reported basic 
impairment among cannabis users is a lack of inhibitory control, particularly when 
required together with other cognitive abilities (Lamers, Bechara, Rizzo, & 
Ramaekers, 2006; Piechatzek et al., 2009; Solowij et al., 2002; Verdejo-García, 
Lawrence, & Clark, 2008). Less consistent results were obtained when investigating 
other executive functions (Piechatzek et al., 2009). When other EF-impairments were 
reported the tasks that were used often also involved an inhibitory component 
(Verdejo-Garcia et al., 2007; Whitlow et al., 2004). Whereas deficits in memory and 
processing speed both appear to be likely consequences of acute and chronic cannabis 
use, deficient inhibitory control has been considered both a potential consequence of 
(chronic) cannabis (and other substance) use and as a vulnerability marker 
predisposing towards substance use. Several studies have suggested a gradual attrition 
of inhibitory control that could be mediated by structural changes in the prefrontal 
cortex (e.g. cell death and tissue shrinkage, decreases in neurogenesis and 
synaptogenesis) (Chanraud et al., 2007; Cowan et al., 2003; Goldstein & Volkow, 
2002; Robinson & Kolb, 2004). Alternatively, deficient inhibitory control may be 
present prior to drug initiation, and represent a vulnerability marker predisposing 
individuals towards recreational use (and mediate the transition to drug dependence) 
(Chambers, Taylor, & Potenza, 2003; Dalley et al., 2007; Kreek, Nielsen, Butelman, 




Further indirect evidence for associations between a lack of inhibitory control and 
cannabis use stems from studies into cannabis and behaviour, which have frequently 
shown associations with impulsive behaviour in daily life (Clark, Rosier, Robbins & 
Sahakian, 2009; Malmberg et al., 2010) or with externalizing (e.g. aggressive and 
delinquent) behaviour characterized by impulsivity deficits (e.g. Fergusson, Horwood 
& Ridder, 2007; Griffith-Lendering et al., 2011; Nelson & Trainor, 2007). Some of 
these studies show that the behaviour problems (and subsequently the possible lack of 
inhibitory control) precede the drug use, providing (indirect) evidence for the 
vulnerability hypothesis (e.g. Griffith-Lendering et al., 2011).  
Despite all the evidence, even inhibitory control deficits among cannabis users have 
not always been replicated (Clark et al., 2009; Pope, Gruber, Hudson, Huestis, & 
Yurgelun-Todd, 2001). Although it is generally very difficult to rule out whether 
sample and methodological differences (e.g. which instruments were used to measure 
inhibitory control?) accounted for mixed results, it is important to consider 
differences in the definition of inhibitory control as well. Inhibition is not a unitary 
construct. Several empirically and statistically-validated taxonomies have been 
proposed. One of these distinguishes inhibition of prepotent responding, resistance to 
distractor interference, and resistance to proactive interference (Friedman & Miyake, 
2004). For cannabis and other substance (ab-) use, inhibition of prepotent responding 
may be most relevant, e.g. the ability to resist automatic response tendencies when 
presented with specific (substance- or non-substance related) cues (Gruber, Silveri, 
Dahlgren, & Yurgelun-Todd, 2011; Gruber & Yurgelun-Todd, 2005; Tapert et al., 
2007). Another taxonomy differentiates cognitive and motivational inhibitory control. 
Cognitive inhibitory control is required for solving abstract, decontextualized 
problems, and motivational inhibitory control is required when problems involve 
regulation of affect and motivation (Huijbregts, Warren, De Sonneville & Swaab, 
2008; Sonuga-Barke, 2002; Zelazo & Müller, 2002). There is neuro-anatomical 
evidence to support this distinction, with relatively more activity in the orbitofrontal 
cortex (OFC) during tasks involving motivational inhibition and relatively more 
activity in the dorsolateral prefrontal cortex (DLPFC) and the anterior cingulate 
cortex (ACC) during tasks involving cognitive inhibition (Krain, Wilson, Arbuckle, 
Castellanos, & Milham, 2006). The two types of inhibition have also been associated 
with different dopaminergic pathways: the mesocortical pathway has been associated 




inhibitory control (Pierce & Kumaresan, 2006; Sonuga-Barke, 2002). Both originate 
in the ventral tegmental area, but the mesocortical pathway particularly innervates 
DLPFC, whereas the mesolimbic dopaminergic pathway passes the nucleus 
accumbens, amygdala, and hippocampus and innervates ventromedial areas/OFC.  
The main question of the present study is whether, among recreational cannabis users, 
cognitive and motivational inhibitory control can be distinguished, i.e. whether they 
show specific problems with either cognitive or motivational control. Although based 
on the existing knowledge cognitive inhibitory control deficits cannot be ruled out, 
there are several reasons to hypothesize that cannabis users will particularly show 
problems with motivational inhibitory control. First of all, several different studies 
have shown motivational deficits in (heavy) cannabis users, both when they were not 
under the influence of THC, the main active component of cannabis, and when they 
were (e.g. Cherek, Lane, & Dougherty, 2002; Lane et al., 2005; 2007). Second, many 
studies provide support for the hypothesis that dysfunctional reward processing, 
which, by definition, involves motivational inhibition, is central to the phenomenon of 
substance abuse (Blum et al., 2000; Nestor, Hester, & Garavan, 2010). Examples are 
studies into implicit cognition which generally involve the memory of the rewarding 
qualities of certain behaviours (Stacy & Wiers, 2010) and (emotional) decision-
making (Bechara, 2003; Busemeyer & Stout, 2002), but also studies showing 
abnormal activation patterns and dopamine dysregulation for substance abusers 
specifically in the brain regions that are part of the reward circuitry (Kamarajan et al., 
2010; Nestor et al., 2010).  
In addition to examining user - non-user differences in laboratory measures of 
inhibitory control, we investigated whether these groups also differ regarding 
impulsive behaviour in daily life. This has been shown before and we expect to 
replicate this finding (Churchwell, Lopez-Larson, & Yurgelun-Todd, 2010; Gruber et 
al., 2011). Based on the fact that the questionnaire used to assess impulsivity in daily 
life contains items with and without motivational components, we expected 







Participants were classified as cannabis users if they reported using cannabis every month 
during the past year and as non-users if they reported the use of cannabis zero times during 
the past year. Based on these criteria (Monshouwer et al., 2006), 53 cannabis users (mean age 
of 22.6, SD=2.4, with an abstinence period of at least 24 hours) and 48 non-users (mean age 
22.3, SD=2.3) were recruited among University of Leiden undergraduate students. Written 
informed consent was obtained from all participants before the start of the study. Ethical 





Cannabis use was assessed by asking participants about their use during the past year and 
month. Participants also reported on the use of alcohol (weekly yes/no), tobacco (daily 
yes/no) and other drugs including stimulants (cocaine, (met)amphetamine), opioids (heroin, 
methadone), and 3,4-methylenedioxymethamphetamine (MDMA: Ecstacy) (past year and 
past month: yes/no, plus frequency of use during past year/month). Impulsive behaviour in 
daily life was assessed with the Barratt Impulsiveness Scale (BIS-11; Barrat, 1985), which 
contains 30 items measuring behavioural impulsivity. Respondents rate statements on a four-
point scale: rarely/never (1), occasionally (2), often (3), or almost always (4). The BIS-11 has 
3 subscales (Barratt, 1985, Miller, Joseph & Tudway, 2004): cognitive impulsivity (8 items, α 
= 0.74), motor impulsivity (11 items, α = 0.59) and non-planning impulsivity (11 items, α = 
0.72). The cognitive impulsivity subscale includes items such as ‘I don’t pay attention’ and ‘I 
have racing thoughts’; the motor impulsivity subscale includes items such as ‘I do things 
without thinking’ and ‘I act on impulse’; and examples of items from the non-planning 
impulsivity subscale are ‘I say things without thinking’ and ‘I get easily bored when solving 
thought problems’ (Stanford et al., 2009).  
 
Neuropsychological tasks 
Two computer tasks were performed individually in a quiet room at Leiden University. 





Cognitive inhibitory control: Response Organization Arrows 
In the Response Organization Arrows task (ROA) from the Amsterdam Neuropsychological 
Tasks (ANT, De Sonneville, 1999), participants had to provide compatible responses in Part 1 
of the task and incompatible responses in Part 2 of the task (For an illustration of this task, 
please see Rowbotham, Pit-ten Cate, Sonuga-Barke & Huijbregts,  2009). An arrow pointing 
either to the right or the left appeared centrally on the computer screen. In Part 1 (40 trials), a 
green arrow appeared. When the arrow pointed to the left, participants had to press the left-
hand mouse button; when it pointed to the right, participants had to press the right-hand 
mouse button. In Part 2 (40 trials), the stimulus was a red arrow. When it pointed to the left, 
participants had to press the right-hand mouse button, and when it pointed to the right, 
participants had to press the left-hand mouse button. A response had to be generated between 
200 and 6,000 ms. The fixed post-response interval was 1,200 ms. Error rates were recorded 
for compatible and incompatible responses. 
 
Motivational inhibitory control: Risky Choice Task 
A version of the Risky Choice Task (RCT) (Fairchild et al., 2009; Rogers et al., 2003) was 
used to measure motivational inhibitory control. Two wheels were presented on screen, each 
containing eight compartments (Figure 1). These compartments showed either possible gains 
or possible losses. The relative number of compartments showing gains provided the relative 
probability of gain for this particular wheel. On eight types of trials, one wheel served as a 
“control” wheel, providing a 50% chance of winning and a 50% chance of losing. The 
alternative, “experimental” wheel varied systematically in terms of the probability of a gain 
(.75 or .25), the magnitude of the possible gain (2 or 8 points), and the magnitude of the 
possible loss (2 or 8 points). Different combinations of these variables yielded eight trial types 
varying in the relative expected value (EV) of the experimental wheel (see Figure 1). There 
were also two trial types with an EV of 0 (the so-called framing trials): one presenting a wheel 
with 50% chance of winning 8 points, and a 50% chance of winning 0 points, and another 
wheel with a 100% chance of winning 4 points (positive framing, denoted as EV: 0+). The 
second presenting a wheel with a 50% chance of losing 8 points and a 50% chance of losing 0 
points, and another wheel with a 100% chance of losing 4 points (negative framing; denoted 
as EV: 0-). All ten trial types were presented twice per block (there were 4 blocks) in a 
pseudorandom order, and participants played four blocks per session. The control and 
experimental wheels appeared randomly on the left or right of the display, and participants 




of each block and were instructed to try to win as many points as possible. Auditory feedback 
on wins or losses was provided and the revised points total was presented for two seconds 
before the next trial (Fairchild et al, 2009).  
 
Figure 1. Example of a trial of the Risky Choice Task. The left wheel represents an 
experimental wheel (expected value = 5.5 (.75*8 - .25*2)), with a high probability of 
winning. The right wheel represents a control wheel (expected value = 0 (0.5*1 – 0.5*1)).  
 
 
Data analyses  
First, it was investigated whether control variables should be included in the main statistical 
analyses as covariates, i.e. whether cannabis users differed from non-users with respect to 
gender, alcohol-, tobacco-, and other drug use, using Pearson Chi-square analyses, and 
whether the potential control variables were related to impulsivity as measured by the BIS-11 
and performance on the two inhibition tasks. Next, group differences between cannabis users 
and non-users regarding impulsivity and inhibitory control were investigated. General Linear 
model (GLM) repeated measures analyses of variance were performed to examine inhibition 
of prepotent responding in the ROA-task, with group (cannabis users vs. non-users) as 
between-subjects factor, response type (compatible versus incompatible) as within-subjects 
factor and error rate as dependent variable. With respect to the RCT, it was first examined 
whether risky or safe choices increased over time, and whether this depended on the number 
of points gained. GLM repeated measures analysis was used to investigate points gained 
during the task, with group (cannabis users vs. non-users) as between-subjects factor and 
block (block 1 to 4) as within-subjects factor. Next, GLM multivariate analysis of variance 




experimental gambles or risky choices (as opposed to control gambles) in general and for 
each trial type (i.e., for each expected value when the gambling choice was made). 
Multivariate analysis of variance was also performed to investigate whether cannabis users 
and non-users differed on the three scales of impulsive behaviour.  
In case there were significant differences between controls and cannabis users, we further 
investigated whether these differences could be attributed to differences between controls and 
heavy users (defined here as cannabis use 11 times or more in the last month), controls and 
moderate users (defined here as 1-10 times in the last month) or both, and whether there were 
significant differences between moderate and heavy users. Because of unequal group sizes 
and unequal variance distributions for relevant dependent variables between the groups, we 
used non-parametric statistics, i.e. Kruskal-Wallis tests for analyses involving all three groups 
simultaneously, and Mann-Whitney tests for comparisons between two groups. 
Finally, Pearson correlations were used to investigate possible relationships between 
impulsive behaviour, cognitive and motivational inhibition.  
 
Results 
Cannabis users and non-users differed with respect to gender distribution, tobacco use, and 
MDMA-use (see Table 1), indicating that, compared to controls, there were relatively more 
men among the cannabis users and cannabis users were more often daily smokers and 
monthly MDMA-users. There were no differences regarding alcohol use, and there were no 
reports of other drug use (e.g. cocaine, amphetamines). Of the factors associated with 
cannabis use, gender was related to all BIS-11 scales of impulsivity: cognitive impulsivity [t 
=3.6, p = .001], motor impulsivity [t =2.9, p = .005] and non-planning impulsivity [t =2.8, p = 
.007]. Men scored higher on all impulsivity measures. Therefore, gender was introduced as a 
covariate in the group analyses comparing impulsivity in daily life between cannabis users 
and non-users. Also, smoking was related to experimental gambling when the EV was -1 [t= -
2.2, p = .033), to performance in the first part of the ROA-task (t= -2.1, p= .040) and to one 
BIS-11 scale, i.e. the motor impulsivity scale [t =3.7, p < .001]. Therefore, smoking was 
introduced as a covariate to the analyses measuring cognitive inhibitory control, motivational 
inhibitory control and impulsivity. MDMA-use was unrelated to task outcomes and 





Table 1. χ²-statistics of cannabis users and non users on control variables (gender, tobacco use 
and alcohol use). 
 Cannabis users Non users χ² 
Male 86.8 % 31.2 % χ2 (1) = 32.5** 
Daily Smokers 65.3 % 6.1 % χ2 (1) = 37.4** 
Weekly alcohol users 88.7 % 75.0 % χ2 (1) = 3.2 
Monthly MDMA-users 22.6% 4.2% χ2 (1) = 7.2** 
* p <.05; ** p <.01 
 
Cognitive inhibitory control: Response Organization Arrows (ROA) 
The repeated measures ANOVA comparing cannabis users and non-users showed no effect 
for group [F(1,99) = .1, p = .794] regarding error rate. There was no significant interaction 
between group and condition (task part) on error rate either (F(1,99) = .5, p = .493]. These 
results indicate that cannabis users and non-users did not differ with respect to cognitive 
inhibitory control.  
 
Motivational decision-making: Risky Choice Task (RCT) 
Performance data 
Firstly, it was investigated whether there were effects for group and group x block (1-4) on 
points gained during the task. The repeated measures ANOVA comparing cannabis users and 
non-users showed no effect for group [F(1,97) = .3, p = .567]. There was no significant 
interaction between group and block regarding points gained during the task either [F(1,97) = 
2.8, p = .096]. These results indicate that both groups gained/lost equal amounts of points 
throughout the task. They also indicate that, as the task progressed, groups did not start to 
differ in the amount of points won/lost.   
 
Group comparisons on choice of experimental gamble by trial type.  
Multivariate analysis of variance showed a significant main group effect of choice of 
experimental gambles [F(10, 90) = 3.5, p = .001, partial η² = .28]. Overall, cannabis users 
chose the experimental wheel more often than non-users. Univariate effects per trial type are 
presented in Table 2. As shown in Table 2, cannabis users chose the experimental wheel more 
often than non-users especially when a choice for the experimental wheel was more risky (i.e. 
when EVs based on relative probabilities were ambiguous or negative).  
After controlling for smoking, there was still a significant main group effect for experimental 




univeriate effects that had been significant initially remained significant after controlling for 
smoking, with the exception of the effect when the EV was .5.  
 
Table 2. Mean proportions of time the experimental gamble was chosen in preference to the 
control gamble for each risky choice task trial type by group (n=101). The difference in 





(Mean %, SD) 
Non users  
(Mean %, SD) 
F- value F-value after 
controlling for 
smoking 
5.5 98.1 % (5.2) 98.2 % (7.7) F(1, 99) = .0 F(1, 98) = .1 
4.0 93.8 %(12.6) 90.2 % (20.7) F(1, 99) = 1.1 F(1, 98) = .2 
1.0 94.5 %( 12.4) 95.3 % (12.9) F(1, 99) = .1 F(1, 98) = .5 
0.5 56.9 % (29.3) 44.0 % (25.1) F(1, 99) = 5.6* F(1, 98) = 3.4* 
-0.5 62.6 % (30.8) 61.0 % (34.3) F(1, 99) = .1 F(1, 98) = .1 
-1.0 18.1 % (19.8) 3.9 % (8.9) F(1, 99) = 20.9 ** F(1, 98) = 15.7** 
-4.0 23.2% (26.5) 13.5 % (19.3) F(1, 99) = 4.4 * F(1, 98) = 4.5* 
-5.5 8.7 % (14.3) 1.0 % (4.6) F(1, 99) = 12.8** F(1, 98) = 11.2** 
0 + frame 87.8 % (19.6) 80.0 % (27.2) F(1, 99) = 2.8 F(1, 98) = .3 
0 - frame  46.2 % (32.7) 30.2 %(26.6) F(1, 99) = 7.1 ** F(1, 98) = 5.0** 
* p <.05; ** p <.01 
 
Impulsive behaviour: the Barratt Impulsiveness Scale  
Multivariate analysis of variance showed a significant main group effect [F(3,96) = 10.0, p = 
.005, partial η² = .24], indicating more impulsive behaviour in daily life among cannabis 
users. Univariate effects were found for cognitive impulsivity [F(1,98) = 19.3, p < .001, 
partial η² = .17]; motor impulsivity [F(1,98) = 18.5, p <.001, partial η² = .16], and non-
planning impulsivity [F(1,98) = 14.4, p < .001, partial η² = .13], with cannabis users scoring 
higher on each of the three impulsivity types measured: cognitive impulsivity (M=17.1, 
SD=2.6 vs. M=14.7, SD = 2.7), motor impulsivity (M=23.4, SD=3.7 vs. M=20.2, SD=3.9) and 
non-planning impulsivity (M=26.5, SD = 4.4 vs. M=23.2, SD=4.2).  
After controlling for gender and smoking, the multivariate main group effect remained 
significant [F(3,94) = 4.6, p = .005, partial η² = .13], as well as univariate effects for  
cognitive impulsivity [F(1,96) = 10.2, p = .002, partial η² = .10] and non-planning impulsivity 
[F(1,96) = 8.7, p = .004, partial η² = .08]. The group difference for motor impulsivity was no 
longer significant, although a non-significant trend was still present [F(1,96) = 3.8, p = .055, 




Influence of frequency of cannabis use.  
Of the cannabis users, 21 had used cannabis up to 10 times in the past month (moderate use: 
39.6%), and 32 had used it 11 times or more (heavy use). First of all, Kruskal-Wallis tests 
with controls, moderate and heavy users confirmed overall group differences (DV: mean 
percentage of choosing the experimental wheel: χ² (2) = 12.0, p = .002). Controls and 
moderate users differed when the EV was 0.5 (Mann-Whitney U = 309.5, z = -2.5, p = .011) 
or -1 (U = 306, z = -3.2, p = .001), and in both the positive and negative framing trials (when 
the EV was 0): U = 345.5, z = -2.3, p = .022, and U = 284.5, z = -2.9, p = .004, respectively. 
In all instances the cannabis users were more inclined than the non-users to choose the 
experimental wheel. Controls and heavy users differed when the EV was -5.5 (U = 458.0, z = 
-4.1, p < .001), -4 (U = 541.0, z = -2.3, p = .019), or -1 (U = 390.0, z = -4.4, p < .001), again in 
every instance indicating a greater tendency to ‘gamble’ among cannabis users. Comparisons 
between the two groups of users did not reveal a consistent pattern: heavy users were more 
inclined to pick the experimental wheel when the EV was -5.5 (U = 292.0, z = -2.0, p = .049), 
whereas moderate users were more inclined to gamble than heavy users when the EV was 0 
(positive framing: U = 235.0, z = -2.1, p = .037).  
With respect to impulsivity in daily life as measured by the BIS-11, Kruskal-Wallis analyses 
showed group differences for attentional impulsivity (χ² (2) = 15.6, p < .001), motor 
impulsivity (χ² (2) = 12.9, p = .002), and non-planning impulsivity (χ² (2) = 14.4, p < .001), 
with both groups of users reporting to be more impulsive than non-users. This was confirmed 
by significant differences between controls and moderate users on all three dimensions: 
Attentional: U = 284.0, z = -2.9, p = .004; Motor: U = 262.5, z = -3.2, p = .002; Non-planning: 
U = 277.0, z = -2.9, p = .004, and between controls and heavy users: Attentional: U = 410.5, z 
= -3.5, p < .001; Motor: U = 507.0, z = -2.6, p = .010; Non-planning: U = 421.0, z = -3.3, p = 





Cognitive inhibition, motivational inhibition & impulsive behaviour.  
Pearson correlations were used to investigate relationships between inhibition as measured by 
the two computer tasks and self-reported impulsive behaviour. Performance on the ROA-task 
was not significantly related to any of the three scales of impulsivity. In contrast, mean 
percentage of trials the experimental gamble which was chosen in preference to the control 
gamble in the RCT was associated with the impulsivity scales ‘cognitive impulsivity’ (r = .24, 
p=.014) and ‘non-planning impulsivity’ (r = .21, p=.038), with a trend for ‘motor impulsivity’ 
(r = .16, p = .050). All correlations indicated that the higher the percentage of trials the 
experimental gamble was chosen, the more impulsivity the participant showed in daily life.  
With respect to specific expected values, attentional impulsivity was significantly correlated 
with choice for the experimental wheel when the EV was -0.5 (r = .28, p = .003), -4 (r = .25, p 
= .005, or 0- (r = .22, p = .015), and non-planning impulsivity was significantly correlated 
with a choice for the experimental wheel when the EV was -1 (r = .20, p = .023), with further 
trends for five other EVs (0.5, -4, 1, 0+, and 0-).  
 
Discussion  
The results of the present study showed that recreational cannabis users differed from non-
users with respect to motivational inhibition. This was particularly evident when the chances 
of reward were small or relatively difficult to estimate. Contrasting results were observed for 
the inhibitory control task without reward (or motivational) component: there were no 
differences whatsoever between cannabis users and non-users. Furthermore, recreational 
cannabis users reported higher levels of impulsive behaviour in daily life, which, in turn, were 
related to motivational but not cognitive inhibitory control as measured by the laboratory 
tasks. It had been expected that both laboratory measures of inhibitory control would be 
related to impulsivity in daily life, as many questions of the BIS-11 do not appear to involve 
motivational or affective components. It may be speculated that, when self-reporting on 
impulsivity, informants generally activate the memory of social contexts where such 
behaviour had to be suppressed in order to reach a certain goal, i.e. when motivational 
processes were involved. This could explain the lack of associations between daily life 
impulsivity reports and cognitive inhibitory control measured in the absence of a socially 
meaningful context.   
Frequency of use did not have a clear influence on the results: there were no differences 




differences regarding measures of motivational inhibitory control, one showing greater 
gambling tendencies for the heavy users, when chances of a reward were quite small, and one 
showing greater gambling tendencies for the moderate users, when chances of a reward were 
difficult to estimate. Together with the type of differences observed between controls and 
moderate users and between controls and heavy users, respectively, this might indicate that 
heavy users are the bigger risk-takers, whereas the moderate users are the greater ‘doubters’, 
but a more consistent pattern of results would be required to substantiate such inferences.    .   
The finding that cannabis users only experienced deficits in inhibitory control when a 
motivational component was present might be indicative of relatively strong reward 
sensitivity that cannot be countered by normal or even good cognitive control skills. For the 
interpretation of this result it may be relevant to consider group characteristics in more detail. 
Cannabis users in the present study were considered recreational users (although a number of 
them reported rather heavy use). Impairments in cognitive inhibitory control have quite 
clearly been established in addicted individuals, and have been suggested to underlie the 
transition into addiction (Everitt et al., 2008; Goldstein & Volkow, 2002; Stacy & Wiers, 
2010; Wiers et al., 2007). Thus, what may distinguish recreational cannabis users from both 
non-users and addicted users is a unique involvement of poor motivational inhibition. Non-
users could have good motivational inhibition, whereas addicted individuals could have both 
poor motivational inhibition and weak cognitive control (see also: Kalivas & Volkow, 2005).  
Regarding specificity of results, this study does appear to provide evidence for some specific 
relations between cannabis use and motivational inhibitory control. Concurrent smoking 
weakened associations to some extent but they remained significant. Alcohol intake did not 
differ between cannabis users and non-users, whilst MDMA-use was not related to any of the 
dependent variables. Although the instruments used to measure substance use were similar to 
those used in other studies into correlates of cannabis use (e.g. Monshouwer et al., 2006), 
these could be further refined (e.g. establish in more detail the intake amounts), and it would 
have been preferable to have multiple informants. Moreover, it may be expected that more 
variation in substance use will be observed in a broader sample of the population. Another 
consideration here is that cannabis users did show different motivational inhibition compared 
to non-users, but that the rewards were unrelated to the substance of interest, which is in line 
with results from other studies (e.g. Kamarajan et al., 2010; Nestor et al., 2010). This appears 
to contrast with implicit cognition approaches, which generally assume spontaneously 
activated memory associations and courses of action involving a specific substance (Stacy and 




examined here (and could therefore just as well produce even stronger evidence for 
motivational inhibition problems in this sample), this result may be indicative of non-
specificity of associations between substance use and motivational inhibitory control (see also  
Fernández-Serrano et al., 2011).  
As mentioned, the instruments used to assess drug use could be further refined. A similar 
argument could be made about the instruments that were used to assess cognitive outcomes. It 
should be noted, however, that the choice for these instruments was based on earlier studies 
investigating the cognitive constructs that are of interest here (Fairchild et al., 2009; Rogers et 
al., 2003; Rowbotham et al., 2009). The cognitive inhibition task used in the present study, 
which is a variant of the well-established Eriksen flanker-paradigm, is a standardized task 
with good reliability and validity scores (De Sonneville, 1999; Rowbotham et al., 2009). In 
order to measure inhibitory control in a motivational context, the most widely used task is the 
Iowa Gambling Task (IGT; Bechara et al., 1994), which indeed has shown differences 
between substance (ab-)using individuals and controls (Bolla, Eldreth, Matochik, & Cadet,  
2005; Verdejo-Garcia et al., 2008; Whitlow et al., 2004). It has however been argued that IGT 
performance deficits particularly reflects decision-making impairments, which, in turn 
involves multiple neuropsychological processes, including working memory, reversal 
learning, and sensitivity to reward/punishment (Busemeyer & Stout, 2002; Dunn, Dalgleish, 
& Lawrence, 2006). Since we wanted to clearly contrast cognitive and motivational 
inhibition, we used a version of the Risky Choice Task (Rogers et al., 2003). In this task it is 
more difficult to use a strategy based on cognitive assertions, i.e. built-up knowledge of 
rewards and punishments (Fairchild et al., 2009). It should however be acknowledged that it 
might have been preferable to have multiple tasks or questionnaires for each construct we 
tested, or perhaps, regarding the outcome measures, to have had two laboratory tasks differing 
purely with respect the requirement of motivational inhibitory control (cf. Daniel & Pollmann, 
2010; Vadhan et al., 2009).  
Despite the obvious opportunities to expand this research, it may be concluded from the 
present study that motivational inhibitory control in recreational cannabis users differs from 
that of non-users, and that the relatively poor impulse control cannabis users show in their 
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Objective: Genetically and/or environmentally determined risk dispositions might increase 
vulnerability of cannabis users to experience psychological problems. Such risk dispositions 
may be expressed as (specific) cognitive weaknesses. The present study examined whether 
relatively poor social perception skills in combination with cannabis use would result in 
higher levels of psychological problems.   
Method:  Cannabis users (N = 75, mean age 24.6 years) were compared to non-users (N = 75, 
mean age 24.7 years) with respect to performance on two social perception tasks (Face 
Recognition (FR) and Matching Facial Emotions (MFE), which can be distinguished from FR 
because it requires emotion recognition and greater working memory capacity) and the extent 
of self-reported psychological problems. Analyses of (co-) variance were used to determine 
whether quality of social perception mediated or moderated possible associations between 
cannabis use and psychological problems. 
Results: Cannabis users performed significantly more poorly than controls on the two social 
perception tasks, and reported more psychological problems than non-users. Quality of social 
perception moderated associations between cannabis use and psychological problems in that 
only users with relatively poor performance on the MFE reported elevated levels of 
psychological problems (i.e. insufficiency of thoughts and actions, distrust, depression, and 
psychoneuroticism). Further specification of the user group showed that the moderation effect 
could be attributed to heavy cannabis users versus moderate- and non-users. No interactions 
were found between cannabis use and FR-performance. 
Conclusion: Heavy cannabis use and relatively poor (complex) social perception skills 





Cannabis is the most widely used substance after tobacco and alcohol in Western countries, 
with a particularly high prevalence among adolescents and young adults (European 
Monitoring Centre for Drugs and Drug Addiction, 2009; Substance Abuse and Mental Health 
Services Administration, 2008). Cannabis use has been associated with poor psychosocial 
adjustment (Fergusson & Boden, 2008; Fergusson et al., 2002; Griffith-Lendering et al., 
2011a) and different (sometimes subclinical) forms of psychopathology, such as psychosis 
(Arseneault et al., 2002; Degenhardt et al., 2003a; Griffith-Lendering et al., in press; Moore et 
al., 2007), antisocial behaviour (Fergusson et al., 2007; Griffith-Lendering et al., 2011b; 
Monshouwer et al., 2006; Rey et al., 2002) and depression (Degenhardt et al., 2003b; 
Fergusson & Boden, 2008; Patton et al., 2002; Rey et al., 2002). In addition, reduced 
educational achievement (Lynskey & Hall, 2000) and cognitive difficulties have been 
reported. Domains of cognitive impairment include executive function (EF), implicit 
cognition, episodic memory, and emotional processing (Pope et al., 2001; Solowij, 1998; 
Solowij et al., 2002; Stacy & Wiers, 2010; Verdejo-Garcia et al., 2008). Many of these 
difficulties have been observed among users of other drugs as well (Fernández-Serrano et al., 
2011). Moreover, there are quite some discrepancies among reported findings (see, for 
example, Fisk & Montgomery, 2008; Pope et al., 2001), which can, in part, be attributed to 
methodological differences between studies. One of these methodological issues concerns the 
definition or operationalization of broad cognitive concepts such as executive function and 
emotional processing. Core EF-abilities include inhibitory control and working memory, 
which are multi-faceted concepts themselves (cf. Christ et al., 2010; D’Esposito et al., 1999; 
Nigg, 2000). Core aspects of emotional processing include social perception (e.g. emotion 
recognition), Theory of Mind (i.e. the ability to “mentalize"), empathy, and 
reward/punishment sensitivity (Adolphs, 2002; Beer et al., 2004; Dodge & Rabiner, 2004; 
Ochsner, 2008; Pettit and Mize, 2007). Studies have often used task paradigms addressing 
combinations of different (social-) cognitive skills. Examples include decision-making and 
implicit cognition tasks, which require working memory, and cognitive and motivational 
inhibitory control (Busemeyer & Stout, 2002; Stacy & Wiers, 2010; Whitlow et al., 2004). 
Aspects of cognition for which it is more difficult to consider them as constellations of other 
cognitive constructs and that appear to be impaired in cannabis users are prospective memory 




further consistent finding is a slower processing and/or motor speed among cannabis users 
(Kelleher et al., 2004).  
In the present study we focused on social perception, which constitutes a basic element of 
social information processing (Dodge & Rabiner, 2004) and has not yet been extensively 
investigated among cannabis users. Social perception tasks may or may not involve emotion 
recognition. The amygdalae play an important role in emotion recognition (Adolphs, 2002; 
Ochsner, 2008). Among long-term cannabis users reduced amygdala volumes have been 
observed (Yucel et al., 2008). Also, Phan et al. (2008) reported reduced amygdala reactivity 
during social information processing after administration of delta-9-tetra-hydrocannabinol 
(Δ9-THC), the principle constituent of cannabis inducing positive emotional states as well as 
anxiety and psychosis-like symptoms (D’Souza et al., 2004). Gruber et al. (2009) showed 
reduced amygdala activity during emotion perception in chronic cannabis users. Although 
these studies yielded relatively consistent results, thereby using stimuli that required the 
ability to recognize emotions from facial expressions, they did not focus on the quality of 
emotion recognition. Only one recent study, by Platt and colleagues (2010), did focus on 
performance during an emotion recognition task. Cannabis users were significantly slower 
than controls at identifying emotional expressions in a paradigm where facial expressions 
gradually changed from neutral to more intense expressions of sadness, anger or happiness. 
Although the authors discussed the possible implications of their findings for vulnerability to 
psychological problems in cannabis users, they did not investigate this further. We sought to 
extend the research by Platt and colleagues by examining social perception in relation to 
psychological problems among cannabis users. With respect to type of psychological 
problems, we focused on subclinical levels of psychosis/schizophrenia, and internalizing and 
externalizing behaviour problems, all of which have been related both to cannabis use 
(Arseneault et al., 2002; Degenhardt et al., 2003a; Fergusson et al., 2002; Moore et al., 2007) 
and to social perception impairments (Demenescu et al., 2010; Germine & Hooker, 2011, 
Kohler et al., 2010; Marsh & Blair, 2008; Rössler et al., 2011). Interrelations between 
psychological problems and cognitive weaknesses in cannabis users have not yet been clearly 
established. Moreover, it is unclear whether cannabis users with cognitive difficulties are 
more prone to (experiencing) psychological problems than cannabis users without such 
difficulties. We hypothesized that cannabis users would perform more poorly than non-users 
on face recognition- and matching emotions from facial expressions-tasks, and would report 




skills and cannabis use would disproportionately increase the chances of experiencing 




Participants were classified as cannabis users if they reported using cannabis every month 
during the past year and as non-users if they reported the use of cannabis zero times during 
the past year. Based on these criteria, 75 cannabis users (mean age: 24.6, SD=3.7, with an 
abstinence period of at least 24 hours) and 75 non-users (mean age: 24.7, SD=3.7) were 
recruited among University of Leiden undergraduate students and through advertisements on 
internet forums concerning cannabis topics. Written informed consent was obtained from all 
participants before the start of the study. Ethical approval for this study was granted by 
Leiden University’s Education and Child Studies Ethics Committee. 
 
Measures 
Cannabis use  
Cannabis use was assessed by asking participants about their lifetime use, their use during the 
past year and month (yes/no, plus frequency of use). Participants also reported on the use of 
alcohol (weekly yes/no), tobacco (daily yes/no) and other drugs including stimulants (cocaine, 
(met)amphetamine), opioids (heroin, methadone), and 3,4-methylenedioxymethamphetamine 
(MDMA: Ecstacy) (monthly: yes/no) (cf. Griffiths-Lendering et al., 2012; Huizink et al., 
2006; Monshouwer et al., 2006) (Table 1).  
 
Psychological problems 
The Symptom Checklist-90 (SCL-90) (Derogatis, 1973; Elliot et al., 2006), a 90-item self-
report symptom inventory developed to measure psychological symptoms and distress, was 
used to measure psychological problems. It was designed to be appropriate for use not only in 
clinical populations but also for use within community samples.  The SCL-90, for which 
items are rated on five-point scales reflecting the extent to which problems were experienced 
in the past 7 days, generates the following scales: Somatic complaints (12 items), 
Insufficiency of thoughts and actions (9 items), Distrust (18 items), Depression (16 items), 
Anxiety (10 items), Hostility (6 items), Agoraphobia (6 items) and Sleeping problems (3 




score of the 90 items. Internal reliability of the different scales ranges from .77-.97 
(Cronbach’s alpha).  
 
Social perception 
Two tasks from the Amsterdam Neuropsychological Tasks (ANT, De Sonneville, 1999), a 
battery of computerized tests, were used to assess social perception. Test-retest reliability, 
construct-, criterion-, and discriminant validity of the ANT-tasks are satisfactory and have 
extensively been described elsewhere (e.g. De Sonneville et al., 2002; Serra et al., 2003; 
Huijbregts et al., 2010). Before each part of a task the participants were given a standard 
verbal instruction and were given the opportunity to ask questions and to practice.  
 
Face Recognition (FR) 
This task (duration: 5 minutes) examined the ability to recognize neutral faces. A target-face 
was presented on the monitor for 2.5s. Following the presentation of the target face, a set of 
four photographs of individuals was presented and participants had to indicate whether or not 
the target individual appeared in the set of four (Figure 1). The gender and age category of the 
target (i.e. boys, girls, men or women) match those of the subsequently shown set of four 
faces. A yes-response was given by pressing the mouse button below the index finger of the 
preferred hand; a no-response required a press of the mouse button below the index finger of 
the non-preferred hand.  There were 40 trials, in half of which the display set contained the 






Figure 1. Stimulus example (target face + display set) and timing of the trials for the Face 
Recognition task  
 
 
Matching of Facial Emotions (MFE) 
This task (duration: 10 minutes) measured the ability to match emotions using facial 
expressions. The expressed emotions are happiness, sadness, anger and fear. In each of the 
160 trials, two (digitized photographs of) faces expressing a particular emotion were 
presented simultaneously on the computer screen. The participants had to press the yes-button 
when the two faces expressed the same emotion and the no-button when the facial emotions 
did not match (Figure 2). MFE may be considered a more demanding task than FR. The tasks 
can also be distinguished based on the fact that MFE specifically involves emotion 
recognition, whereas FR does not.   
 





First, Pearson correlations were calculated to get an impression of which 
psychological problems were associated with cannabis use (lifetime, past year and 
month).  
Next, group differences between cannabis users and non-users regarding 
psychological problems and performance on the social perception tasks were 
investigated using General Linear Model (GLM) univariate and multivariate analyses 
of variance. Accuracy and speed of task performance were first analyzed separately. 
In order to account for potentially slower processing speed among cannabis users and 
to account for possible speed-accuracy trade-offs, ratio variables (i.e. number 
correct/mean RT for correct responses) were calculated and used as dependent 
variables in further analyses of task performance. In order to investigate the role of 
social perception in potential differences between cannabis users and non-users 
regarding psychological problems, participants were assigned to groups with either 
relatively poor or relatively good social perception (based on mean RT-corrected 
accuracy scores during the tasks). Next, two-way (multivariate) analyses were 
performed with cannabis use and social perception as between-subjects factors and the 
scales of the SCL-90 as dependent variables. Separate analyses were performed for 
social perception operationalized as Face Recognition and Matching Facial Emotions. 
Control variables (gender and other substance use) were included in the analyses as 
covariates when they were related to both dependent and independent variables. 
In order to get an impression of possible dose-dependency, the two-way multivariate 
analyses of variance were repeated comparing non-users to relatively moderate users 
(<40 times in the past year) and relatively heavy users (≥ 40 times in the past year).  
 
Results 
Lifetime cannabis use correlated significantly with SCL-90 dimensions insufficiency 
of thoughts and actions (r = .19, p = .012), depression (r = .17, p = .025), anxiety (r = 
.21, p = .006), hostility (r = .24, p = .002), and the overall psychoneuroticism score (r 
= .21, p = .007), with a trend for the correlation with distrust (r = .13, p = .067). 
Cannabis use in the last 12 months was significantly correlated with insufficiency of 
thoughts and actions (r = .18, p = .014), distrust (r = .17, .023), and hostility (r = .21, p 




anxiety (r = .13, p = .060). Similar correlations were observed for cannabis use in the 
last four weeks and SCL-90 dimensions (insufficiency of thoughts and actions: r = 
.14, p = .047; distrust: r = .18, p = .019; hostility r = .20, p = .007; and 
psychoneuroticism r = .12, p = .078). For the other dimensions of the SCL-90, 
somatic complaints, agoraphobia, and sleep problems, no significant correlations with 




Error rates on both the FR- and the MFE tasks were significantly higher for cannabis 
users compared to non-users [FR: F(1,148) = 18.0, p < .001, partial η² = .11; MFE: 
F(1,148) = 10.8, p = .001, partial η² = .07]. Cannabis users were also significantly 
slower than non-users in the MFE-task [F(1,148) = 5.9, p = .017, partial η² = .04], but 
there was no significant difference in response speed for the FR-task [F(1,148) = 1.2, 
p = .28, partial η² = .01]. Significant group differences regarding both speed and 
accuracy in the MFE-task were present for pairings involving matches of all four 
different emotions, i.e. happiness, sadness, anger and fear (see Table 2 for descriptive 
statistics on task performance and psychological problem ratings). In order to 
incorporate in further analyses the fact that cannabis users performed less accurately 
and more slowly than non-users in the MFE-task, and in order to take into account the 
possibility of speed-accuracy trade-off in the FR-task, ratio-variables (number 
correct/mean RT for correct responses) were used. A MANOVA comparing users and 
non-users on the FR- and MFE ratio-scores showed a significant multivariate group 
effect [F(2,147) = 5.4, p = .006, partial η² = .07], with significant univariate effects for 
both tasks: FR: F(1,148) = 4.0, p = .047, partial η² = .03; MFE: F(1,148) = 10.7, p = 
.001, partial η² = .07, indicating poorer performance of cannabis users. Cannabis users 
differed from non-users with respect to gender distribution (relatively more men 
among cannabis users) (Table 1), and women performed better on the social 
perception tasks (FR: t(146) = -1.9, p = .06; MFE: t(146) = -2.7, p = .008). However, 
entering gender as a covariate in the above analyses did not affect the group 
differences on social perception between cannabis users and non-users 
With respect to behavior problems significant differences between users and non-
users were observed for insufficiency of thoughts and actions [F(1,132) = 4.1, p = 




further trends for anxiety [F(1,132) = 3.3, p = .070, partial η² = .03] and 
psychoneuroticism [F(1,132) = 3.5, p = .065, partial η² = .03]. All results indicated 
higher scores for cannabis users; these were also observed for distrust and depression, 
although here the group differences were not significant (Table 2).    
When FR- or MFE-scores were introduced to these analyses as covariates in order to 
examine possible mediation effects, the only difference between cannabis users and 
non-users that was significantly reduced was that for insufficiency of thoughts and 
actions when the MFE-score was controlled for [F(1, 131) = 2.5, p = .12, partial η² = 
.02).  
 
Table 1. Descriptive information on cannabis users (n=75) and non-users (n=75)  
 Users Non-users   t / ÷2 
Age (Mean, SD) 24.7 (3.7) 24.6 (3.7) t(148) = 0.0 
Male  66.7 % 30.7 % ÷2 (1) = 21.2** 
Daily smokers 41.3 % 9.3 % ÷2 (1) = 20.3** 
Weekly alcohol   92.0 % 76.0 % ÷2 (1) = 7.1* 
Monthly MDMA 14.7% 5.3% ÷2 (1) = 3.6+ 
Monthly cocaine 4.0% 1.3% ÷2 (1) = 1.0 









Table 2. Means error rates and RTs (SD’s) of cannabis user and non-user groups on the social 
perception tasks and mean scores on the Sympom Checklist-90 
 Non-users  
(n = 75) 
Moderate  users 
(n = 41) 
Heavy 
users (n = 34) 
Face Recognition   ER 1.6 (1.2) 2.9 (2.2) 2.7 (2.0) 
                               RT 1281 (259) 1310 (303) 1341 (237) 
MFE Happiness     ER 0.9 (0.7) 1.2 (1.6) 1.7 (1.9) 
                               RT 1194 (240) 1310 (334) 1278 (266) 
MFE Sadness         ER 6.4 (3.9) 8.7 (5.1) 9.1 (4.0) 
                               RT 1819 (383) 1986 (490) 1971 (373) 
MFE Anger            ER 5.5 (4.0) 6.4 (5.3) 7.8 (4.4) 
                               RT 1778 (382) 1904 (422) 1908 (350) 
MFE Fear               ER 4.9 (3.5) 5.9 (4.3) 8.1 (4.5) 
                               RT 1797 (398) 1959 (494) 1944 (338) 
Somatic complaints 15.7 (3.6) 16.5 (5.5) 15.2 (3.0) 
Insuff. thoughts and actions 12.3 (3.5) 13.1 (4.3) 14.5 (4.5) 
Distrust 22.3 (5.0) 22.1 (4.3) 25.7 (8.0) 
Depression 20.6 (5.3) 22.4 (7.6) 22.4 (7.3) 
Anxiety 11.9 (3.0) 13.1 (5.3) 13.2 (3.1) 
Hostility 7.0 (1.3) 7.6 (3.0) 8.6 (3.8) 
Agoraphobia 7.4 (1.2) 7.4 (1.7) 7.6 (1.1) 
Sleep problems 4.6 (2.4) 4.6 (2.1) 4.2 (1.3) 
Psychoneuroticism 112.1 (21.6) 118.1 (29.0) 122.8 (27.8) 
Moderate users: reported use of cannabis < 40 times/past year; Heavy users: reported use of 





When groups with relatively poor and relatively good social perception were formed (split at 
mean for FR- and MFE-ratio scores) and introduced to the analyses as a second independent 
variable (next to cannabis use) some clear moderation effects emerged for performance of the 
MFE-task. Significant interactions between cannabis use and MFE-performance were observed 
for insufficiency of thoughts and actions [F(1,130) = 5.6, p = .019, partial η² = .04], distrust 
[F(1,130) = 4.0, p = .048, partial η² = .03], depression [F(1,130) = 4.5, p = .036, partial η² = .03], 
and psychoneuroticism [F(1,130) = 5.0, p = .027, partial η² = .04]. These moderation effects 
indicated that psychological problems of cannabis users were evident among those who also 
performed relatively poorly on the MFE-task (see Figure 3a-d). Cannabis users did not differ 
from non-users when they performed relatively well on this task (see Table 3 for results of 




In analyses where cannabis use was further subdivided into relatively moderate (<40 times in the 
past year) and relatively heavy use (≥ 40 times in the past year), significant interactions were 
again observed for insufficiency of thoughts and actions [F(2,128) = 4.2, p = .017, partial η² = 
.06], distrust [F(2,128) = 3.4, p = .018, partial η² = .06], and psychoneuroticism [F(2,128) = 3,4, 
p = .037, partial η² = .05], with a trend for depression [F(2,131) = 2.7, p = .07, partial η² = .04] 
(see Figure 4a-d). These interactions indicated that psychological problems were particularly 
observed for heavy cannabis users with relatively poor social perception as measured by the 
MFE.  
Cannabis users and non users differed with respect to gender distribution, and they also used 
tobacco, alcohol, and MDMA more often than non-users (Table 1). None of these factors were 
significantly associated with psychological problems. Adding them as covariates did not affect 
the interactions between cannabis use and MFE-performance predicting psychological problems. 
No significant interactions were observed between cannabis use and FR-performance when 
predicting psychological problems. 
 
Table 3. Helmert contrasts for psychological problems 
 Contrast Estimate (SE), Sig. 
 Insufficiency of 
thoughts and 
actions 
Distrust Depression Psychoneuroticism 




.424 (.18), .019* .484 (.18), 
.008** 
.501 (.19), .008** 
Level 2 vs. 
later 
-.007 (.22), .976 .071 (.22), .750 -.001 (.22), .995 .072 (.23), .751 
Level 3 vs. 
Level 4 
-.261 (.23), .260 -.418 (.24), .078 -.214 (.23), .356 -.316 (.24), .189 
* p <.05; ** p <.01 
Level 1: Cannabis use + poor social perception; Level 2: Cannabis use + good social perception; 







Figure 3. Moderating effects of social perception quality (MFE-performance) on associations 







Figure 4. Exposure-dependent moderating effects of social perception quality on associations 




The results of this study show that compared to non-users, cannabis users reported more 
insufficiency of thoughts and actions, hostility, anxiety and psychoneuroticism. Furthermore, 
cannabis users performed more poorly than non-users on the social perception tasks, with the 
greatest differences observed for the matching emotions task. Another important question was 
whether quality of social perception would mediate or moderate associations between cannabis 
use and psychological problems. Whereas there was little evidence supporting mediation effects 
(except for insufficiency of thoughts and actions), the moderation hypothesis was confirmed by 
the finding of interactions between cannabis use and performance on the Matching Facial 
Emotions-task in predicting insufficiency of thoughts and actions, distrust, depression, and 
psychoneuroticism. Cannabis users who performed relatively poorly on that task had the most 
pronounced psychological problems. Cannabis users with relatively good performance on the 
task did not report elevated levels of psychological problems compared to non-using controls. It 




used to measure social perception. Thus, the moderating effects are only apparent when the 
social perception task is either more demanding (for example, because of the requirement of 
additional cognitive skills in order to perform the task) or when it specifically involves the 
perception of emotional expressions. It should also be noted that it is not entirely clear yet 
whether these results are specific to cannabis use. Group differences and interactions were not 
affected by introducing other substance use or gender as covariates to the analyses. However, in 
order to measure other substance use dichotomous measures were used and, even though 
cannabis users more often reported the use of other substances as well, other substance use did 
not predict the type of psychological problems measured here. More continuous variables 
incorporating dosage or frequency of use, as selected to measure cannabis use, may be preferable 
for other substances as well (cf. Fernandez-Serrano et al., 2010). The associations between 
cannabis use and psychosis/schizophrenia-type (subclinical) psychological problems appears to 
concur with results from earlier studies (Arseneault et al., 2002; Degenhardt et al., 2003a; Moore 
et al., 2007; Rössler et al., 2011), although one should be careful in categorizing hostility and 
anxiety/depression as part of the spectrum of psychosis-/schizophrenia-type problems. They 
could represent independent psychological problems as well.  
Whereas this study does not cover directionality of effects, relatively strong evidence exists 
indicating that cannabis use precedes or increases the risk of psychosis/schizophrenia-type 
problems (possibly on top of the so-called self-medication effects where increased vulnerability 
to develop psychosis is “soothed” with substance use) (Casadio et al., 2011). It is however clear 
that only a minority of cannabis users develop actual psychosis, and there is an intensive search 
under way for factors that might compound the effects of psycho-active cannabis ingredients in 
this respect. Most attention has been given to genetic factors enforcing susceptibility towards 
development of psychosis (Caspi et al., 2008; Henquet et al., 2008). Although inevitably 
influenced by genetic and environmental factors as well, specific cognitive weaknesses may, in 
combination with cannabis exposure, also increase chances of developing psychosis. This is 
what the present study suggests for social perception (as measured by the MFE), although it may 
be argued that better instruments could be available for detecting psychosis, also at a subclinical 
level in generally healthy populations (e.g., the Community Assessment of Psychic Experiences 
– CAPE, Stefanis et al., 2002; or the Symptom Checklist-90-R, Olsen et al., 2004; Rössler et al., 
2011) and that a wider range of instruments should be used to cover (and clearly distinguish) all 
possible (combinations of) (social-)cognitive abilities where relative weakness could increase 
mental health effects of cannabis use. This view is supported by neurophysiological data: 
whereas a relatively singular pathway from cannabis to psychosis has been proposed, in which 




glutaminergic terminals causes disruptions in dopaminergic projections from the brain stem to 
the striatum (Morrison & Murray, 2009), there are relatively high concentrations of  CB1-
receptors throughout the prefrontal and anterior cingulate cortices (Casadio et al., 2011; 
Yacubian and Büchel, 2009). This, in turn, would suggest more widespread (social-)cognitive 
abnormalities that might increase the risk of experiencing psychological problems following 
heavy and prolonged cannabis use.          
When these issues are further resolved, a clinical implication of our findings could be that social 
perception will be targeted in programs aimed at reducing the risk of psychopathology following 
cannabis use and possibly even in programs aimed at the prevention or treatment of addiction. 
Whereas more evidence is required to confirm a role for social perception in addiction 
progression, our findings do indicate more serious social perception deficits among heavier, and 
thus more likely to be addicted users. Recreational cannabis users and addicted substance users 
appear to have different cognitive outcomes (Everitt et al., 2008; Kalivas & Volkow, 2005; Stacy 
& Wiers, 2010). Whereas this has particularly been investigated with respect to inhibitory 
control (indicating more comprehensive inhibitory control deficits for addicted substance users), 
similar distinctions may be present for other aspects of cognition as well.  
 
In conclusion, it may be stated that this study has provided evidence showing that cannabis users 
have problems with social perception in comparison to non-using controls, particularly when 
these social perception skills involve emotion recognition and need to be used in combination 
with other (e.g. working memory) skills. Moreover, heavy cannabis users experience 
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Summary and Integration of main results 
 
Cannabis use and mental health 
In general, our studies confirm that cannabis use is related to different mental health 
problems. Firstly, we focused on the prospective relationship between cannabis and 
both internalizing and externalizing behaviour problems. Results showed that 
cannabis use during adolescence was associated with the risk for externalizing 
behaviour. More specifically, after controlling for potentially confounding factors, 
including the use of other substances, path analyses showed that level of externalizing 
problems (measured at age 11 and 13) predicted the risk for cannabis use a few years 
later (measured at age 13 and 16, respectively). Cannabis use did not predict later 
externalizing behaviour. These findings supported the so called ‘self-medication’ 
hypothesis, where mental health problems precede the use of cannabis (Khantzian , 
1985). We also studied cannabis use and its relation to internalizing behaviour 
problems. Results showed however that internalizing problems were unrelated to 
cannabis use.   
The next focus was on the prospective relationship of vulnerability for psychosis and 
cannabis use during adolescence. After controlling for potentially confounding 
factors, symptoms indicative of the risk for psychosis at age 13 and 16 predicted 
cannabis use at age 16 and 19, respectively.  Although our earlier study indicated that 
externalizing behaviour did precede cannabis use, but did not increase following use 
of cannabis, vulnerability for psychosis followed use of cannabis (at age 16), 
therefore allowing the conclusion that cannabis also predicted mental health problems 
(i.e. psychosis vulnerability at age 19). Hereby, evidence was provided not only for 
the self-medication hypothesis (as for externalizing behaviour), but also for the 
damage hypothesis, which suggests that cannabis use induces neurobiological 
changes leading to different forms of psychopathology (Brook, Cohen & Brook, 
1998; Kandel, Yamaguchi & Chen, 1992; Moore et al., 2007).  
 
Both studies described above provided evidence for the self-medication hypothesis, 




vulnerability) preceded cannabis use during adolescence. Previous evidence 
supporting the self-medication hypothesis stems from clinical observations of patients 
suffering from psychiatric disorders (e.g. Klein et al., 1994; Warner et al., 1994). 
Here, those suffering from psychiatric disorders tend to self-medicate (or sooth) the 
associated psychiatric distress by using cannabis. Indeed, it has been hypothesized 
that those suffering from psychosis symptoms use cannabis to improve their mood or 
control their feelings, to improve sleep, and reduce anxiety and agitation (Schofield et 
al., 2006). However, there are also studies that indicate that individuals with 
symptoms of psychosis use cannabis for reasons similar to those of the general 
population, i.e. ‘to get high’, relax and have fun (Kolliakou et al., 2001). This may be 
particularly plausible in the present study sample, as it consists of a group of 
adolescents drawn from the general population. In the case of externalizing behaviour 
problems, previous studies have also shown that problem behaviour precedes 
cannabis use (Fergusson et al., 2007; King et al., 2004; Pederson et al., 2001). 
Possibly here, those suffering from externalizing behaviour problems use cannabis to 
get rid of anger and hostile feelings. Alternatively, adolescents with externalizing 
behaviour problems are likely to show sensation seeking behaviour, which may be 
expressed in a greater tendency to use substances (Huizink et al., 2006; Marsman et 
al., 2008; Raine, 1996). 
 
In addition to evidence for the self-medication hypothesis, the present study also 
provided evidence for the damage hypothesis, where the use of cannabis leads to the 
development of various mental health problems, although this was only observed for 
vulnerability to psychosis. This result corroborated findings from earlier studies, 
which also showed cannabis use to precede psychosis (Ferdinand, 2005; Fergusson et 
al., 2003; Kuepper et al., 2011; Moore et al., 2007), and also appears to be in line with 
neurobiological findings indicating relatively specific effects of delta-9-tetra-
hydrocannabinol (Δ9-THC), the main psycho-active ingredient of cannabis, on 
systems/brain networks involved in psychosis/schizophrenia. Thus, a bidirectional 
relationship was observed between cannabis use and vulnerability for psychosis 
during adolescence. Interestingly, when cannabis use preceded psychosis 
vulnerability, this became apparent during late adolescence, which might indicate 
stronger damaging effects of cannabis when it has been used over a longer period of 




plays an important role in this context. Psychosis usually becomes evident during 
young adulthood, which would mean that predictors of psychosis, including cannabis 
use, have a greater amount of phenotypic variability to predict at later ages. Although 
this could also be true for the proxy variables used here to represent psychosis 
vulnerability, i.e. social, attention, and thought problems, it seems likely that these 
have a greater amount of phenotypic variability at earlier ages. Future research should 
address the “cascading” effect for cannabis use and psychosis vulnerability in more 
detail, also taking into consideration differential susceptibility to cannabis exposure 
based on genetic and/or environmental vulnerability.  
This relates to the vulnerability hypothesis, which states that the cause and effect 
relationship of cannabis use and mental health problems might be moderated by 
particular forms of vulnerability, i.e. biological, personal or familial factors that 
increase chances of both substance use and mental health problems (Caspi et al., 
2005; Henquet et al., 2005; Miller et al., 2001; Verdoux et al., 2003). Such factors 
could also render individuals more vulnerable to the effects of cannabis, which, 
subsequently, might increase chances to develop not only the types of mental health 
problems discussed above, but also substance abuse and substance dependence (Hicks 
et al., 2011; Kendler et al., 2003). Preliminary evidence from one of the smaller 
samples supported the vulnerability hypothesis (see section “Cannabis Use and 
Cognitive Functioning”).  
In the studies on temporal order of cannabis use and different mental health problems, 
we have controlled for several well-known confounding factors (e.g. use of other 
substances, parental psychopathology), when analysing associations between cannabis 
use and mental health problems, thereby largely ruling out the so called ‘shared 
causes hypothesis’. This hypothesis argues that the linkage between cannabis use and 
mental health problems is largely non-causal and may be the result of several factors 
associated with the use of cannabis and mental health problems, such as 
disadvantaged background and difficult childhood circumstances (Fergusson & 
Horwood, 1997; Fergusson, Horwood & Swain-Cambell, 2002a). However, according 
to Hawkins, Catalano & Miller’s 1992 and Petraitis, Flay & Miller’s 1995 risk factor 
taxonomies, confounders can be categorized into (1) socio-environmental variables, 
including gender and SES; (2) substance-related variables, including the use of 
alcohol and tobacco; (3) intrapersonal variables, including mental health problems 




brought up by both parents (Von Sydow et al., 2002). As we could not incorporate all 
possible confounders (from the different categories) of cannabis – mental health 
associations (e.g. family functioning, relationship with mother, drug-using peers/ 
family), we cannot completely rule out “shared causes”. Future research could address 
this issue by providing a more comprehensive study of potential confounders, 
although it should be noted that it appears impossible to include all possible factors 
related to both substance use and mental health problems.  
 
Cannabis use and Social Functioning 
The second aim of this dissertation was to determine the influence of difficulties in 
social skills as possible risk factors for cannabis use, early initiation age of cannabis 
use and high frequency of use during adolescence. Mental health problems are often 
characterized or aggravated by problems in social skills (Fergusson et al., 2002; 
Tarbox & Pogue-Geile, 2008).  Transitions into addiction or problematic substance 
use do not only occur amongst those with (obvious) mental health problems. To learn 
more about the relation between social skills and the risk for cannabis use, we studied 
cannabis correlates in a non-clinical cohort of adolescents, providing a particularly 
suitable context for investigating social skills in relation to cannabis use. There may 
be much more variation in social skills in this population than in a population 
characterized by mental health problems. We hypothesized that associations between 
cannabis use and social skills may not always be straightforward in that poor social 
skills would be associated with higher chances of (early initiation of) substance use 
(which would correspond with the self-medication hypothesis for mental health 
problems). After all, many adolescents consider cannabis a ‘social drug’, which is 
used mainly with friends, to ‘bond’ and to ‘hang out’ (Lee et al., 2007). Therefore, we 
tested whether different social skills differentially predicted cannabis use. Results 
showed associations between social parameters and cannabis use, where both 
cooperation and assertive behaviours at age 11 were related to cannabis use at age 16. 
More specifically, higher levels of assertive behaviour were associated with higher 
levels of cannabis use, whereas lower levels of cooperative behaviour at age 11 
predicted higher levels of cannabis use at age 16. In other words, cannabis users were 
less cooperative, as expressed in, for example, complying with rules and directions, 




might indicate that young adolescents who more readily engage in relations with 
peers and others, are also more likely to use cannabis. There were no associations 
with the social skill “self-control”, and specific predictions of early versus late onset 
of use or frequency of use could not be made either. Previous studies however have 
found associations between cannabis use and self-control (Pokhrel et al., 2007; 
Sussman et al., 2003). Possibly, different operationalizations of self-control could 
explain differences in study results. Whereas in the present study, self-control was 
defined as ‘behaviours that emerge in conflict and non-conflict situations’, and was 
rated by the participant’s teachers (Gresham, 1990), others have defined this type of 
behaviour as ‘one’s tendency to act without thinking’ and the behaviour was often 
judged or scored by, for example, experimenters or parents  (Tarter, 1988). A lack of 
(involvement in) conflict situations in the classroom may have resulted in less 
variability in self-control scores, and subsequently a lack of associations with 
cannabis use. Indirect support for this suggestive explanation stems from our finding 
of significant associations between cannabis use and impulsive behaviour in daily life 
(chapter 5).   
The concept of social skills or functioning in relation to substance use appears very 
interesting, but social functioning should be operationalized in different ways, and, as 
our results show, no unidirectional effects may be expected. The finding that 
cooperative behaviour reduced the chances of adolescents using cannabis, whereas 
assertive behaviour (also usually considered a social strength) increased the chances, 
emphasized that different aspects of social functioning may have differential relations 
with substance use. 
  
Cannabis use and Cognitive Functioning 
In previous sections we disucssed our findings indicating that when specific mental 
health problems (also at subclinical levels) were present, or when specific social skills 
had not developed optimally, chances of (initiating) drug use were higher. Evidence 
was also provided to suggest interrelations between cannabis use and poor social 
skills and mental health problems on the one hand, and cognitive difficulties on the 
other. Pre-existing mental health problems and social skills may, like particular 
cognitive weaknesses (e.g. in areas necessary for behaviour regulation) either 




associations between cannabis use and (further) mental health or behaviour problems. 
Mental health problems (including addiction and substance abuse) and poor social 
skills are often found to be associated to particular cognitive dysfunctions, suggesting 
specific underlying neurocognitive mechanisms that can help explain associations 
between substance use and behaviour. Consequently, development of cognitive 
abilities is frequently targeted in treatment of mental health problems or training of 
social skills. They are often found to be required in order for treatment or training 
programs to be effective. Therefore, investigating possible cognitive difficulties 
among cannabis users is highly relevant.  
Cannabis use (like use of many other substances) has been associated with many 
different cognitive weaknesses. Previous studies did not always opt for administration 
of neuropsychological tasks that addressed singular cognitive domains, which we 
consider necessary to disentangle different contributing elements. Therefore we 
attempted to select cognitive tasks with clearcut measurement potentials. We 
compared performance of cannabis users and non-users on tasks distinguishing the 
following functions: inhibition  (with and without an motivational aspect) and social 
perception (with and without the element of recognizing emotions). 53 Cannabis-
users (mean age of 22.6) and 48 non-users (mean age of 22.3) were compared on 
inhibitory control and impulsive behaviour. Results showed that cannabis users 
differed from non-users on motivational inhibition. Interestingly, cannabis users did 
not differ from non-users on inhibitory control without a motivational component. In 
addition, cannabis users reported higher levels of impulsive behaviour in daily life. 
This behaviour was related to motivational inhibitory control, but not to inhibitory 
control without the motivational component.  
In our other study on cognitive abilities and cannabis use, 75 cannabis users (mean 
age 24.6 years) and 75 non-users (mean age 24.7 years) were compared with respect 
to performance on two different social perception tasks, one addressing the ability to 
recognize faces and the other addressing the ability to match facial emotions. The 
second task can be distinguished from the first as it requires emotion recognition and 
more working memory capacity. Also, cannabis users and non-users were compared 
on specific psychological problems. Results show that cannabis users experience 
more problems on the two social perception tasks and reported more psychological 
problems, i.e. more insufficiency of thoughts and actions, hostility, anxiety and 




between cannabis use and psychological problems. Only cannabis users with 
relatively poor performance in the matching emotions-task showed significantly 
elevated levels of psychological problems. Non-users and cannabis-users with good 
social perception as measured by the matching emotions task did not. Moreover, the 
interactions were only observed when the matching emotions task was used as a 
measure for social perception, not when the face recognition task was used. Thus, 
specific weaknesses in emotion recognition (and possibly working memory) seem to 
play an important role (cf. Solowij & Battisti, 2008). Moreover, the effect was dose-
dependent: psychological problems were particularly experienced by heavy cannabis 
users with relatively poor social perception as measured by the matching emotions 
task. 
 
It may be concluded from the previous TRAILS studies into social and behavioural 
correlates of cannabis use that the presence of symptoms of (subclinical) 
psychopathology, including vulnerability for psychosis and externalizing behaviour 
problems, may increase the risk of cannabis use. Cannabis use, in turn, may increase 
the risk of developing or deteriorating further (specific) mental health problems. 
Social functioning (regardless of the presence or absence of (subclinical) levels of 
psychopathology) also influences the chances that people will be inclined to use 
cannabis, although it should be taken into account that some aspects of social 
functioning increase chances of cannabis use, whereas others reduce these chances.  
 
Whereas the previous studies on the TRAILS-sample described in this thesis focused 
on the temporal order of cannabis use and mental health problems, the last two studies 
investigated possible underlying mechanisms explaining behavioural difficulties. The 
study on social perception (chapter 6) could be regarded as supportive of the 
vulnerability hypothesis. Studies have shown that different biological or 
environmental factors moderate associations between cannabis use and mental health 
outcomes. However, rather than focusing on genetics, as a number of earlier studies 
have done (Caspi et al., 2005; Henquet et al., 2008, Gill et al., 2010; Rijsdijk et al., 
2011), we focused on aspects of cognition (which are of course themselves influenced 
by genetic make-up and environmental factors) in order to examine the vulnerability 
hypothesis for cannabis use and psychological problems. Evidence was provided 




of psychological problems among heavy cannabis users. Future research on this issue 
would benefit from prospective designs, in order to find out whether (specific) 
cognitive weaknesses early in life predispose towards cannabis use and mental health 
problems later on, and to find out whether the combination of cognitive vulnerability 
and cannabis use disproportionately increase the risk for developing mental health 
problems.  
 
Critical reflections and directions for future research  
Some critical notes should be made when interpreting results of the present thesis. 
Throughout all studies (chapter 2-6) we made use of self-reported data to determine 
cannabis use (tobacco and alcohol use were also self-reported). Questions concerning 
initiation age and frequency of use might have led to socially desirable answers, 
especially for young adolescents. Although this may have been the case, there are 
several studies that have concluded that self-reporting of substance use is generally a 
valid method (e.g. Bushan et al., 2002). Also, cannabis use is generally condoned in 
the Netherlands, which possibly allows for more honest self-reports of cannabis use 
compared to studies in other countries with stricter cannabis policies. Data on mental 
health and behaviour (externalizing symptoms, internalizing behaviour, vulnerability 
for psychosis, social behaviour, impulsive behaviours) were also obtained from self-
reports. Use of multiple informants would have been preferable (Offord et al., 1996). 
 
One particular strength is the focus on temporal order of behavioural and social 
correlates of cannabis use within a large population based sample (n=2,230). Also, the 
starting point of TRAILS is early adolescence (Mean age T1: 11.1), hereby providing 
the opportunity to collect prospective data antedating initiation to cannabis in very 
early starters and to investigate multiple hypotheses on cannabis use and behaviour 
difficulties. 
The focus on early adolescence is relevant for several different reasons. During 
adolescence, rapidly developing biological changes (puberty) and maturation 
processes take place. These developmental processes might make the human 
organism vulnerable for enduring effects of external influences such as exposure to 
cannabis (Court, 1998; Schneider 2008). Indeed, different studies have shown that 




effects of cannabis use, including impaired reaction times (Ehrenreich et al. 1999), 
mental health problems and behaviour difficulties (Arsenault et al., 2002; Fergusson 
et al., 2002a, 2002b). Early onset delinquents, for example, not only show earlier 
onset of cannabis use, but also a much faster rate of increase in cannabis dependence 
symptoms (Lynskey et al., 2002). Thus, early adolescence seems to be characterized 
by a heightened risk for irreversible effects, and a heightened risk for more significant 
adverse outcomes as well.  
 
A limitation of the series of studies presented in this thesis is that we were only able 
to select a limited amount of potential confounders to introduce to our analyses. 
Therefore, we may have missed a number of other factors that could also be important 
correlates of cannabis use and mental health problems during adolescence. For 
example, we have not investigated the issue of a possible heightened sensitivity for 
the effects of cannabis in individuals with a particular genetic make-up, or have done 
so only indirectly, based on the assumption that the genes of interest partly determine 
certain cognitive outcomes. Experimentation with cannabis use might be harmless for 
some, but quite harmful for other children, and patterns of cause and effect might 
differ accordingly. Children enter adolescence with different levels of inherited and 
acquired psychobiological vulnerability (or conversely, resilience) to mental disorder 
due to differences in a person's genetic make-up (Loehlin, 1992, Rutter et al., 1999). 
Although parental psychopathology may be seen as a clear marker for vulnerability in 
children, which we have controlled for in the present study, this does not directly 
investigate genetic make-up of their children.  
A further recommendation for future research is to focus on a broader age span and 
longer follow-ups to investigate the relationships with mental health problems 
(including internalizing problems, externalizing behaviour and vulnerability for 
psychosis). There are several reasons for this. First of all, at the second measurement 
wave, the number of adolescents who used cannabis, but also the frequency of use, 
was relatively low. It is assumed that more adolescents will start using cannabis 
during later adolescence, around the age of 15 (Monshouwer et al., 2005). Also, the 
sample was quite young and had not been using cannabis for a long period of time, 
thereby possibly reducing the chances of finding support for the so called ‘damage 
hypothesis’ in relation to internalizing and externalizing behaviour problems. Studies 




adulthood (Fergusson et al., 2002; White et al., 1999). Possibly, such effects will also 
become evident in our sample at a later stage. Lastly, it can be assumed that some of 
those who started using at a young age, may start using it more frequently in late 
adolescence, which in turn forms an extra risk factor for the development of 
behaviour and cognitive deficits as well as addiction (Substance Use Disorders). 
Another recommendation for future research is to include instruments measuring 
other aspects of social functioning as well, now that we have provided additional 
evidence for differential relations between different social skills and cannabis use.  
For example, in order to measure social functioning, we focused on three specific 
skills in relation to cannabis use. Examples of instruments which could be used in the 
future include the Scale for Interpersonal Behavior (Arrindell & van der Ende, 1985), 
to assess frequency and associated distress during social interaction, the Novotni 
Social Skills Checklist to assess a wider range of social skills, and the Youth Self 
Report (Achenbach, 1991; Verhulst and Achenbach, 1995) and the Strengths and 
Difficulties Questionnaire (Goodman, 1997) to assess social and peer problems next 
to social skills.  
 
 
Clinical implications  
The results of our studies may have implications for clinical and preventive practices. 
First and foremost, the present study has shown that prevention programs should take 
into consideration presenting information on associations between cannabis use and 
mental health problems, especially during adolescence. As described earlier, 
adolescence is a life phase characterized by brain maturation and growth, which might 
increase the risk of possible damaging effects of cannabis (Schneider et al., 2008). 
Prevention programs should also focus on certain vulnerable groups, such as 
adolescents suffering from psychosis symptoms or exhibiting externalizing behaviour 
problems. These individuals may tend to self-medicate by using cannabis, already 
during adolescence. Since these behavioural difficulties could further develop into 
clinical disorders with poor long-term outcomes, prevention programs should focus 





Considering social functioning in relation to cannabis in prevention programs, it 
should be considered to fine-tune the approach to different social skills, and not 
simply stimulate all positive social skills. Previous studies have shown different ‘life 
skills’ to be effective in prevention of cannabis use, including self-esteem (Tobler et 
al., 2000), focus on norms, commitment not to use and intention not to use (Cuijpers 
et al., 2002). Also, a ‘social influence approach’ seems effective in prevention, where 
the focus is, among others, on assertiveness (Donaldson et al., 1996; Cuijpers, 2002; 
Tobler et al., 2000). However, these assertive skills were mainly defined in the 
context of ‘resistant skill training’; in other words, it seems effective to be ‘assertive 
to say no to drugs’. Here, being assertive seems an effective preventive approach. The 
present study however, showed that being assertive in somewhat different contexts or 
situations may also serve as a risk factor of using cannabis. It may be concluded that 
adolescents need to show specific assertive behaviour, so it can operate as a protective 
factor in drug using behaviour. Also, the present study showed that prevention 
programs should stimulate cooperation, since higher levels of cooperation served as a 
protective factor in the prediction of cannabis use.  
Lastly, substance use disorders have been associated with impaired decision-making 
and increased impulsive behaviour, which may be due to lack of motivational 
inhibitory control. This study showed that cannabis users also experience difficulties 
with social perception. Therefore, it may be considered to include training of social 
perception and motivational inhibitory skills in prevention and intervention programs. 
These aspects of cognition have not yet featured prominently in existing programs, 
which have focused on, for instance, management of negative thinking, problem 
solving skills and relaxation training. Further research is required to identify more 
comprehensively the range of  (social) cognitive abilities that are impaired in cannabis 







Given the five research questions of this study, we can conclude the following: 
During early adolescence, there is no association between internalizing behaviour and 
cannabis use. There is an association between externalizing behaviour and cannabis 
use, where externalizing behaviour precedes cannabis use rather than the other way 
around. Secondly, during adolescence, there is an association between psychosis 
vulnerability and cannabis use, where cannabis use predicts psychosis vulnerability 
and vice versa, suggesting a bi-directional cascading association.  
Thirdly, during early adolescence, the social skill “self-control” was (unexpectedly) 
unrelated to cannabis use. Cooperation and assertiveness are associated with cannabis 
use during this life phase, where higher levels of cooperation decrease the chance of 
using cannabis and higher levels of assertiveness increase the chance of using 
cannabis during early adolescence.  Cooperation and assertiveness did not 
differentiate between early and late onset of cannabis use or predict frequency of use. 
In addition, compared to non-users, cannabis users experience problems only in 
motivational inhibitory control, not in cognitive inhibitory control. Also, cannabis 
users experience problems in behavioural impulsivity, which is related to motivational 
inhibitory control.  
Lastly, cannabis users have problems with social perception in comparison to non-
using controls, particularly when these social perception skills involve emotion 
recognition. Also, heavy cannabis users experience significantly more psychological 
problems when they have relatively poor social perception skills.  
Future research must determine whether the behavioural and cognitive concepts and 
constructs examined in this thesis in relation to cannabis use should be incorporated  
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Cannabis use has been associated with a wide range of mental health problems, 
including psychotic disorder, aggressive and delinquent behaviour (externalizing 
behaviour problems), depression and anxiety (internalizing behaviour problems). To a 
lesser extent, cannabis use has been associated with specific social skills deficits, 
including low social self-control, self-esteem problems and lower social competence. 
Also, there are reports of cannabis users experiencing cognitive difficulties, including 
memory problems, slower processing speed, specific deficits in complex planning and 
other executive dysfunctions.  
For the present thesis, the temporal order of associations between cannabis use and 
internalizing and externalzing behaviour as well as psychosis vulnerability was 
investigated. Furthermore, interrelations between possible cognitive dysfunctions and 
behavioural and mental health problems among cannabis users were examined. Also, 
the cognitive and social profiles of cannabis users were examined in more detail. 
Different hypotheses have been proposed in order to explain associations between 
cannabis use and mental health problems or behaviour difficulties. The damage 
hypothesis proposes that cannabis use precedes behavioural difficulties. Conversely, 
the self-medication hypothesis proposes that behavioural difficulties precede cannabis 
use. The shared causes hypothesis argues that the linkage between cannabis use and 
mental health problems is largely non-causal and may be explained by other factors 
associated with the use of cannabis and mental health problems. Finally, the 
vulnerability hypothesis states that the linkage between cannabis use and mental 
health problems might be particularly evident in individuals who are, due to their 
biological, personal or familial make-up, particularly sensitive to the damaging effects 
of cannabis or more likely to use drugs for their soothing effects.  
The first aim was to determine the temporal order of cannabis use and mental health 
problems during (early) adolescence. Secondly, we focused on social parameters in 
association with cannabis use. The third aim was to investigate several cognitive 
correlates of cannabis use, namely social perception and inhibitory control, thereby 





The five main research questions of this thesis were outlined in the general 
introduction (chapter 1): 
1. Is there a relationship between cannabis use and both internalizing and 
externalizing behaviour problems in early adolescence? And if so, what is the 
temporal order of these relationships? 
2. Is there a relationship between cannabis use and vulnerability for psychosis, as 
measured by social problems, thought problems and attentional problems, in 
adolescence? And if so, what is the temporal order of this relationship?  
3. Are the social skills cooperation, assertiveness and self-control precursors of 
cannabis use during early adolescence? Specifically, are these social skills 
precursors of (early) cannabis initiation and the frequency of use?  
4. Do cannabis users experience problems with motivational inhibitory control, 
cognitive inhibitory control or both? Also, do cannabis users experience 
problems in behavioural impulsivity, and is this related to motivational and/or 
cognitive inhibitory control?  
5. Do cannabis users experience problems with respect to social perception? 
Also, are cannabis users with problems in social perception more likely to 
experience psychological problems? 
 
Research questions 1-3 were investigated using data from a large prospective cohort 
study of Dutch adolescents named TRAILS; Tracking Adolescents Individual Lives 
Survey. With respect to temporal associations the following results were obtained 
(described in chapter 2 and chapter 3). Cannabis use was not related to internalizing 
behaviour problems. In contrast, externalizing behaviour problems were related to 
cannabis use, where externalizing problems (measured at age 11 and 13) predicted 
cannabis use (measured at age 13 and 16, respectively). Cannabis use did not predict 
externalizing behaviour. These findings supported the self-medication hypothesis, 
where mental health issues precede cannabis use.  Vulnerability for psychosis at age 
13 and 16 predicted cannabis use at age 16 and 19, respectively. An important 
difference with the results of the analyses of cannabis-externalizing behaviour 
associations was that cannabis use (at age 16) also predicted mental health problems 
(i.e. vulnerability for psychosis at age 19). Hereby, evidence was provided for both 




cannabis use induces neurobiological changes leading to different forms of 
psychopathology.  
With respect to research question #3, on whether social skills could predict (different 
aspects of) cannabis use, results showed that both cooperation and assertiveness could 
predict cannabis use, although in different ways. Low levels of cooperative behaviour 
at age 11 were associated with cannabis use at age 16, whereas higher assertiveness at 
age 11 predicted cannabis use at age 16 (chapter 4). Cooperative and assertive 
behaviour did not discriminate between early and late onset of cannabis use or predict 
frequency of cannabis use, and, unexpectedly, self-control was unrelated to cannabis 
use.  
 
Research questions 4 and 5 were addressed using data from two samples of (mostly) 
undergraduate students.  Cannabis users differed from non-users with respect to 
motivational inhibition, but not with respect to inhibitory control without a 
motivational component. Also, cannabis users reported higher levels of impulsive 
behaviour in daily life. This behaviour was related to motivational control, but not to 
inhibitory control without the motivational component (see chapter 5). Cannabis 
users also performed relatively poorly when social perception was required (chapter 
6). This was observed in two tasks, one involving the ability to recognize faces and 
the other involving the ability to recognize and match facial emotions. Differences 
compared with non-using controls were particularly evident for the task involving 
emotion recognition. Also, cannabis users reported more psychological problems, 
namely more insufficiency of thoughts and actions, hostility, anxiety and 
psychoneuroticism. Quality of social perception as measured by the task involving 
emotion recognition, moderated associations between cannabis use and psychological 
problems, in that only relatively heavy users with relatively poor social perception 
reported significantly elevated levels of psychological problems.  
Whereas findings reported in chapters 2 and 3 provided (partial) evidence for the self-
medication hypothesis and the damage hypothesis, the findings regarding social 
perception provide some evidence supporting the vulnerability hypothesis. No 
evidence was found for the shared-causes hypothesis, although it should be noted that 
we were necessarily limited to a relevant but selective number of potentially 
confounding variables. These and other limitations as well as possible implications 









Het gebruik van cannabis is gerelateerd aan een breed scala van psychische 
problemen, waaronder psychotische stoornissen, agressief en delinquent gedrag, 
depressie en angst. Ook zijn er verbanden aangetoond tussen cannabisgebruik en 
problemen met specifieke sociale vaardigheden, zoals sociale zelfbeheersing en 
gevoel van eigenwaarde. Daarnaast is er bewijs dat cannabisgebruikers vaker 
problemen ervaren met bepaalde cognitieve vaardigheden zoals verschillende 
geheugenprocessen, informatieverwerkingssnelheid en executieve functies.  
Voor het huidige onderzoek zijn deze verbanden opnieuw onderzocht, maar zijn er 
accenten geplaatst op tot nog toe onderbelichte kanten van die relaties. Zo is 
geprobeerd verbanden te leggen tussen mogelijke cognitieve problemen enerzijds en 
(mogelijke) gedrags- en psychische problematiek anderzijds.  Ook werden aspecten 
van het cognitief en sociaal functioneren belicht die tot nog toe weinig zijn 
onderzocht, met een nadruk op mogelijk differentiële verbanden met cannabisgebruik. 
Een verder belangrijk onderzoeksdoel was het vaststellen van de “volgorde” van de 
associatie tussen cannabisgebruik en psychische- en gedragsproblemen. Er zijn 
verschillende hypothesen geformuleerd ten aanzien van de temporele volgorde van 
cannabisgebruik en psychische – en gedragsproblematiek. Zo stelt de ‘damage 
hypothese’ dat cannabisgebruik voorafgaat aan psychische problemen. Omgekeerd 
stelt de ‘self-medication hypothese’ dat psychische problemen voorafgaan aan 
cannabisgebruik. De ‘shared causes hypothese’ stelt dat het verband tussen 
cannabisgebruik en psychische problemen grotendeels kan worden verklaard door 
factoren die zowel aan cannabisgebruik als aan psychische problemen zijn 
gerelateerd. Als laatste stelt de ‘vulnerability hypothese’ dat de relatie tussen 
cannabisgebruik en psychische problemen met name aanwezig is bij personen die, 
vanwege hun biologische, persoonlijke of familiare achtergrond of omgeving, 
gevoelig zijn voor de schadelijke effecten van cannabis (als bij de damage hypothese) 
of mogelijk een hogere kans hebben om cannabis te gaan gebruiken voor de 




De vijf belangrijkste onderzoeksvragen zijn beschreven in de algemene introductie 
(Hoofdstuk 1): 
1. Is er een relatie tussen cannabisgebruik en zowel internaliserende als 
externaliserende gedragsproblemen tijdens de vroege adolescentie? En zo ja, 
wat is de temporele volgorde van deze relatie? 
2. Is er een relatie tussen cannabisgebruik en kwetsbaarheid voor psychose, 
gemeten aan de hand van sociale problemen, denkproblemen en 
aandachtsproblemen, tijdens de adolescentie? En zo ja, wat is de temporele 
volgorde van deze relatie? 
3. Voorspellen de sociale vaardigheden coöperatief gedrag, assertiviteit en 
zelfbeheersing cannabisgebruik tijdens de vroege adolescentie? En zijn deze 
sociale vaardigheden ook voorspellers van (vroege) initiatie van cannabis  en 
frequentie van cannabisgebruik?  
4. Ondervinden cannabisgebruikers problemen met motivationele inhibitie, 
cognitieve inhibitie of beide? En zijn deze inhibitievormen gerelateerd aan  
impulsiviteitsproblemen in het dagelijks leven? 
5. Ondervinden cannabisgebruikers problemen met sociale perceptie? En, 
ervaren cannabisgebruikers met sociale perceptie-problemen vaker psychische 
problematiek? 
 
Onderzoeksvragen 1-2-3 werden beantwoord met behulp van gegevens uit een groot, 
prospectief, algemeen bevolkingsonderzoek onder Nederlandse jongeren, genaamd 
TRAILS; Tracking Adolescents Individual Lives Survey. In hoofdstuk 2 en 
hoofdstuk 3 werd bepaald of  internaliserende- en externaliserende gedragsproblemen 
en kwetsbaarheid voor psychose vooraf gingen aan cannabisgebruik of daar juist op 
volgden. Internaliserende gedragsproblemen hadden geen verband met 
cannabisgebruik. Externaliserende gedragsproblemen daarentegen hadden wel een 
verband met cannabisgebruik, waarbij externaliserende gedragsproblemen (gemeten 
of de leeftijd van 11 en 13) het gebruik van cannabis voorspelden (gemeten op de 
leeftijd van, respectievelijk, 13 en 16 jaar). Cannabisgebruik voorspelde 
externaliserende gedragsproblemen niet. Deze bevindingen zijn in overeenstemming 
met de  self-medication hypothese, waarbij psychische problemen voorafgaan aan 
cannabisgebruik. Kwetsbaarheid voor psychose, gemeten op de leeftijd van 13 en 16 




verschil met  het verband tussen cannabis-externaliserende gedragsproblemen was dat 
het gebruik van cannabis (op de leeftijd van 16 jaar) ook kwetsbaarheid voor 
psychose (op de leeftijd van 19 jaar) voorspelde. Met andere woorden, in de relatie 
tussen psychotische kwetsbaarheid en cannabisgebruik is er bewijs gevonden voor 
zowel de self-medication hypothese als de damage hypothese, die suggereert dat het 
gebruik van cannabis neurobiologische veranderingen met zich mee brengt die 
kunnen leiden tot verschillende vormen van psychische problematiek.  
 
Wat betreft de relaties tussen sociale vaardigheden en (verschillende aspecten van) 
cannabisgebruik (onderzoeksvraag 3) werd gevonden dat zowel coöperatie als 
assertiviteit cannabisgebruik voorspelden, maar op verschillende manieren. 
Coöperatief gedrag verlaagde de kans op het gebruik van cannabis, terwijl assertiviteit 
juist de kans verhoogde (hoofdstuk 4). Coöperatief en assertief gedrag konden niet  
vroege versus late initiatie van cannabisgebruik voorspellen, en waren ook niet 
voorspellend voor de frequentie van cannabisgebruik. Tegen onze verwachtingen in 
was de vaardigheid zelfbeheersing niet gerelateerd aan cannabisgebruik.  
 
Onderzoeksvragen 4 en 5 werden beantwoord met behulp van gegevens uit twee 
steekproeven bestaande uit (voornamelijk) studenten. Cannabisgebruikers verschilden 
van niet-gebruikers op motivationele inhibitie, maar niet op cognitieve inhibitie. Ook 
scoorden cannabisgebruikers hoger op impulsief gedrag in het dagelijkse leven. Dit 
gedrag was gerelateerd aan motivationele inhibitie, maar niet aan cognitieve inhibitie 
(hoofdstuk 5). Cannabisgebruikers presteerden ook relatief slechter op sociale 
perceptie-taken  in vergelijking met niet- gebruikers (hoofdstuk 6). De slechtere 
prestaties  werden waargenomen bij een gezichts- en een emotieherkenningstaak 
(waarbij de emotieherkenningstaak ook een groter beroep deed op het werkgeheugen) 
De verschillen ten opzichte van niet-gebruikers waren het grootst op de 
emotieherkenningstaak. Cannabisgebruikers rapporteerden ook meer psychologische 
problemen, namelijk meer insufficiëntie van denken en handelen, vijandigheid, angst 
en psychoneuroticisme. Opvallend was dat relatief zware cannabisgebruikers met 
relatief slechte sociale perceptie (als gemeten met de emotieherkenningstaak) 
significant meer psychische problemen hadden dan niet-gebruikers en gebruikers met 
relatief goede sociale perceptie, hetgeen impliceert dat cognitieve kwetsbaarheid een 




Waar de bevindingen uit hoofdstuk 2 en 3 (gedeeltelijke) ondersteuning opleverden 
voor zowel de self-medication hypothese als de damage-hypothese, ondersteunen de 
bevindingen uit hoofdstuk 6 de vulnerability-hypothese. Ook deze laatste hypothese 
zou echter het beste verder kunnen worden onderzocht in longitudinale studies. In dit 
proefschrift is er geen bewijs gevonden voor de shared causes hypothese, al moet 
opgemerkt worden dat we slechts een beperkt aantal potentieel betrokken factoren 
konden onderzoeken. Deze en andere beperkingen, samen met implicaties voor 
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